Predicting drug effectiveness in Cancer Cell Lines using Machine Learning and Graph Mining by Diogo Vaz Nunes
FACULDADE DE ENGENHARIA DA UNIVERSIDADE DO PORTO
Predicting drug effectiveness in Cancer
Cell Lines using Machine Learning and
Graph Mining
Diogo Nunes
Mestrado Integrado em Engenharia Informática e Computação
Supervisor: Rui Camacho (FEUP)

Predicting drug effectiveness in Cancer Cell Lines using
Machine Learning and Graph Mining
Diogo Nunes
Mestrado Integrado em Engenharia Informática e Computação

Resumo
O cancro é uma doença heterogénea, com um nivel de diversidade entre tumores considerável. Os
biomarcadores, no contexto de uma doença oncológica, permitem a identificação da capacidade
de resposta de um paciente a um dado fármaco. Estes tratamentos especificos têm produzido re-
sultados em média superiores aos de uso mais abrangente. No entanto a ligação entre a resposta ao
tratamento e o valor de um dado biomarcador é em muitos casos ainda desconhecida. O objectivo
deste projecto é, com base em resultados prévios e na caracterização tanto dos fármacos como dos
tecidos celulares, conseguir prever a eficácia de um fármaco em um tumor utilizando técnicas de
Graph Mining e Machine Learning. Um modelo anterior será usado como base, começamos por
replicá-lo e experimentamos com a sua transformação num problema de classificação e com a in-
trodução de substructuras moleculares dos fármacos encontradas através do uso de Graph Mining.




Cancer is an heterogeneous disease, with a high degree of diversity between tumours. Biomarkers,
in the context of an oncological disease, allow the identification of the response from a patient to
a given drug. These specific treatments have been producing results that are superior on average
to broader ones. However, the relationship between a drug’s response a biomarkers value is in
many cases yet unknown. Some models to predict this relationship have already been built, using
machine learning methods. The input are characterizations of both the drug and the tissue along
with the result of the drug’s use on a given tissue. The goal of this thesis is to improve on previous
models and the characterization of both the drug and the tissue through the introduction of graph
mining and other machine learning methods. A previous model will be used as a baseline, we
start by replicating it and we experiment with it’s transformation into a classification problem










“You should be glad that bridge fell down.
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This project, in it’s simplest description, consists of trying to predict the effectiveness of a drug on
a tissue using machine learning. By using mathematical representations of both cell lines, drugs
as inputs it is possible to predict the inhibitory values. Other projects have followed this approach,
we will start by replicating their steps, analyze them and add and analyze graph mining concepts.
In the following sections the motivation, goals and document structure will be described.
1.1 Motivation
Cancer is currently one of the leading causes of death in the world with an annual number of
cases of 14 million and a mortality rate of about 50% [1]. It is expected that the number of cases
rise 70% over the next two decades. The effects of both the disease and the treatments are also
associated with a deterioration of the quality of life of the affected individual [2]. No one size fits
all cure for it has been found so far and treatment relies mostly on chemotherapy.
Cancer has long been known to be a heterogeneous disease with a diverse number of tumour
profiles - each tumour is made of cells with a different genetic profile. Therapies that can target
specific profiles, named targeted therapies, have shown superior results contributing to the grow-
ing belief that targeting specific profiles will allow for more efficient treatments [3]. Examples are
Trastuzumab, which targets the ERBB2 biomarker and has been shown to increase the survivor
rate of early breast cancer treatments by 3.3% [4], and Imatinib targeting BCR-ABL [3]. How-
ever, approved drugs remain at a low number and their usage in treatments remains scarce. The
relationship between biomarker values and a drug effectiveness remains mostly unknown and it is
cumbersome and costly to experiment on all possible tissues which is why a computerized model
that could predict this relationship would be valuable.
Cultures of cancer cells have been developed by laboratories through the growth of human-derived
tumour cells in vitro. These cell lines can then be used to reliably test the effects of drugs as they
have the same genetic characteristics as the original tissue. This has enabled high throughput test-
ing resulting in a large amount of collected data.
The use of Machine Learning (ML) and Data Mining enables the processing of larger amounts
1
2 Introduction
of data for pattern finding without explicitly programming them. It has been used in this particu-
lar field, it’s use in the prediction of drug efficiency in cancer cells has been 20% more accurate
than statistical methods [5]. Using available previously performed cell line experiments, with cell
line data and drug molecular information it’s possible to create a model to predict future drug
reactions. There are a number of existing models following this approach [5]–[7] each using a
different dataset. Most achieved encouraging results and reasonable accuracy but still falling short
of providing a replacement for laboratory experimentation.
1.2 Goals
The goal of this project is to better understand the relationships between cancer cells and the
effectiveness of a drug in order to improve the drug’s administration and provide more specific
treatments. This goal will be achieved through the construction of a model that can predict the
effectiveness of a drug. Besides being able to predict the effectiveness it’s also important that
we can acquire information about the inputs, results and effects achieved. We will first replicate
Menden et al. experiments which uses cell line and IC50 values from the Genomics in Drug
Sensitivity project with added drug information. After analyzing the model, sub-molecules found
through Frequent Subgraph Mining will be added and their performance also analyzed.
1.3 Document Structure
Beyond this introductory Chapter 1, this dissertation’s Chapters are structured in the following
way. The second Chapter 2 details the relevant state of the art topics. In the next Chapter 3 the
methodology for the experiments performed is detailed with the results discussed in Chapter 4.
Finally, in the final Chapter 5, the overall goal satisfaction and future work possibilities are dis-
cussed.
Chapter 2
Biology and Data Mining Concepts
This chapter provides an overview of the state of the art focusing on the relevant subjects for this
dissertation. The first section contains brief explanations of biology concepts necessary for the
understanding of the work done, followed by a similar overview for cheminformatics. On the
third section a description of the Data Mining process and concepts can be found. The chapter
concludes with a description of relevant machine learning concepts and algorithms.
2.1 Biology Concepts
Cancer
Cancer is a group of diseases originated from the uncontrolled and abnormal growth and multi-
plication of cells [8]. The process comes from the failure of a cell to replace itself and instead
divide indefinitely. These cells will then, except in blood cancer (leukemia) form a tumour. This
phenomenon can happen on any of the body’s organs, the cancer’s name usually takes after organ’s
(ex. Brain Cancer). If left unchecked the cell growth will impair the functioning of local organs,
cause body-wide issues such as fatigue and fever and may eventually lead to death.
Cancer is a major disease affecting a large number of people. It is is the second leading cause of
death worldwide, in 2012 14 million contracted cancer and in 2015 it caused 8.8 million deaths [9].
The aberrant cells that compose the tumour go through a unique combination of genetic changes
making them different for every patient. In addition the cells and blood vessels around the tumour,
known as it’s microenvironment, influence the tumour and vice-versa. These innumerous possible
changes and environments mean that cancers are heterogeneous diseases [10] [11].
Biomarkers
There is no clear definition of what a biomarker is. The broadest definition is by the Center for
Biomarkers in Imaging which considers a biomarker any "physiological, biochemical or molecular
parameter associated with the presence and severity of specific disease states" [12]. Blood pressure
or urine samples are examples of what can be considered a biomarker under this definition. They
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can perform one of three functions - diagnostic biomarkers can help diagnose a condition, prog-
nostic biomarkers help predict the diseases’ aggressiveness and predictive biomarkers are used to
forecast a treatment’s effectiveness. Predictive and prognostic biomarkers are key for identifying
drugs that can target a tumours’ specific characteristics and achieve higher therapeutic perfor-
mance.
In cancer they are used to characterize the tumour and its microenvironment attempting to identify
it’s driving mutations [3], allowing for more targeted therapies. They can be found at either the
molecular, cellular or tissue level.
Cell Culture
Cell cultures are cells grown in artificial environments (in vitro) by supplying them in "the appro-
priate nutrients and conditions" [13]. They are used to further study the cell and test drugs, among
others.
Cell lines
A cell from a culture has a limited life span. To prevent their death and to allow easier experimen-
tation they can be subcultured (passaged) into a cell line [14]. The main advantage is their lower
maintenance and cost of use, the negatives include the dangers of contamination between different
cultures in a single line and a less accurate representation of the original tissue. There are some
doubts about their ability to evaluate a drug’s effectiveness but there is a scientific consensus that
they presently are the best possible tool to evaluate it [11]. Cell lines have a long use history in
cancer research, the National Cancer Institute 60 (NCI60) introduced cell line screening to cancer
drug testing. It was developed in the 1980s and contained 60 cancer cells lines for testing. It is
considered a scientific landmark in cancer research, a number of new technologies were developed
and applied that remain cornerstones of cell line screening. Interest in Cancer cell line research
has been reinvigorated due to the increased understanding of cancer’s heterogeneity. Which also
made the need to increase the number of cell lines it clear so more diverse sets of cells can be
represented. Today there are cancer cell lines available with a higher number of cell lines that can
be used to test targeted therapeutics.
IC50
The inhibitory concentration 50 (IC50) is a common measure of a drug’s effectiveness. It repre-
sents the amount of an inhibitor that is required to halve the effectiveness of a biological process
[15]. It’s ubiquitous use is due to the lower variance from experience environments and easily
calculable standard error [16].
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Genome
The genome is the genetic material contained inside an organism [17]. It is mostly comprised by
the Deoxyribonucleic acid (DNA), which contains the instruction set for an organism to develop.
Every cell contains a copy of the DNA and analysis has shown it’s influence in cancer tumour
formation [18]. Some DNA concepts that are relevant to the project are introduced in the following
paragraphs.
Copy Number
The copy number is the number of repetitions in certain DNA sections. Around 5 to 10% of
human DNA is comprised of repetitions [19], these repetitions or deletions can help characterize
a genome especially since copy number anomalies are more common in tumour cells due to their
frequent mutations [18] .
Phenotype
The phenotype are the "observable characteristics" of an organism due to it’s gene expression,
according to the National Cancer Institute [20]. The wildtype phenotype refers to the phenotype
of an organism as seen in nature, in other words - it’s standard version. Other variants are referred
to as mutations. In cancer, since cells undergo a significant number of mutations, analyzing the
mutator phenotype can provide insight into treatment possibilities [21].
Microsatellite Instability
Microsatellite instability (MSI) is a phenomenon caused by a damaged mismatch repair (MMR)
system in the DNA. It’s presence has proven to be a reliable cancer predictor [22]. The DNA
MMR is a system that fixes DNA errors during replication and recombination, if it is faulty then
cells are likely to accumulate errors which makes them more prone to abnormal behavior.
2.2 Cheminformatics
Cheminformatics is the application of computer technology to chemistry problems [23]. It entails
the extraction of information from chemical process through computer - in-silico - models.
Quantitative structure–activity relationship
Quantitative Structure–activity relationship (QSAR) is a name given to computer models that at-
tempt to predict the link between a molecular structure and it’s biological activity [24]. Its process
encompasses the representation of a molecule in a digital readable representation, and model con-
struction, usually using data mining and statistical analysis methods, and model evaluation [23].
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Molecular Descriptors
Molecular descriptors [25] are mathematical representations of the structure of a molecule in a
way that allow statistical computation or for other information technologies to be used on the
characterization of the molecule. They can be either obtained by experimental measurements or
can be derived through symbolic representation of the molecule. Molecular descriptors can be
categorized by the dimensions they describe. 0D-Descriptors merely contain information derived
from the chemical formula of the molecule such as the number of atoms, 1D-Descriptors are
based on the structural representation and fragments of that structure, mass and bond types for
example. 2D-Descriptors are based on a graph model which allows a topological representation of
the molecule from which we can derive measures such as graph connectivity, as an example. 3D-
Descriptors adds the spatial representation of the molecule creating a full geometric description.
4D-Descriptors also include molecular interaction fields and electron distribution.
Chemical File Formats
There are several file types for molecular representation, the most relevant for this thesis are intro-
duced in the following sections.
SMILES
Simplified molecular-input line-entry system (SMILES) is a specification for representing molecules
as ASCII strings. For example Di-nitrogen, that has two nitrogen elements connected through a
triple bond, would be represented as N#N.
Chemical table files
Chemical table files are formats for representing the information contained in tables. SDF is a
format for representing chemical information. SDF stands for structured data format, it contains
the structure of the molecule in addition to some general information about it[26].
Available Tools
There are free available tools that can be used to compute molecular descriptors. Open Babel [27]
is a software package that can calculate a molecule’s fingerprint and also convert chemical files
between formats. It provides bindings for several formats and is licensed under the GNU General
Public License. To calculate molecular descriptors PADEL-descriptor [28] is a popular choice.
This software can handle the computation of most molecular descriptors, through the use of its
own algorithms and by wrapping the Chemistry Development Kit [29].
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2.3 Data Mining
Data Mining [30] is the process of extracting knowledge from unorganized and large amounts of
data. The basic steps of the process involve the cleaning, integration, selection and transformation
of the data; these first steps are typically named the preprocessing steps. The main step is the
mining itself where methods, usually involving machine learning, are applied to the data to extract
the information in the data, typically patterns. Finally, the results are evaluated to determine the
usefulness of the patterns found and presented. A simple version of the process is illustrated in
figure 2.1. It’s frequent for these steps to then be combined in more complex combinations. The
Figure 2.1: Overview of a basic Data Mining process
Cross Industry Standard Process for Data Mining (CRISP-DM) [31] is a common process model
used in Data Mining. It formalizes the additional step of understand the data and it’s context before
preprocessing while also considering the process an iterative looped process where the model is
reanalyzed after the evaluation is performed. Figure 2.2, taken from IBM’s knowledge center [32],
represents this process.
Data Preprocessing
Data preprocessing [30] encompasses the process of treating data so that it fits to a certain standard
of quality before it is used by an application. Big data warehouses with data from various sources
are prone to bad quality resulting from missing or inaccurate values or different formats among
others. The negative factors affecting the data we are focused on removing in this preliminary step
are the lack of accuracy, completeness, consistency and interpretability.
Preprocessing can be divided in several steps: Data Cleaning where routines are created to
fill missing values and smooth the data. Data reduction where the original data set is either com-
pressed or split while trying to maintain the insights of the same data set, and data integration
which consists maintaining the quality of the data while introducing a new data set.
Data cleaning deals with the inconsistency, noise and missing values usually by the creation
of routines that run regularly. To deal with missing values we have several options. The simpler
ones are ignoring the data record or filling the value manually. There are more complex ways
of filling the data, we can use the median of the values of other tuples, additionally we can run
a classification algorithm beforehand and use only the objects of the same class to calculate the
median. It is also possible to use machine learning algorithms to calculate the most probable value.
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Figure 2.2: Overview of the CRISP-DM process. Taken from IBM’s knowledge center.
Data reduction strategies can be divided in dimensional reduction ones where it is attempted
to project the data into a smaller set, numerical reduction is based on using smaller forms of data
representation and compression where a smaller data set is constructed with no information loss.
In the context of work done this step will encompass the transformation of the drugs into
molecular descriptors and the treatment of the cell line features.
Feature Selection
Feature selection in data mining is the process of selection a subsection of the feature space with
minimal information loss. This is accomplished by finding and removing present mostly redundant
data [33]. There are various benefits in having a smaller feature subset [34]. The risk of over-
fitting the model to the training will be smaller. Data will be easier to interpret and visualize and
the model will be trained faster using less storage. The identification of redundant data is also
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valuable in itself as it allows for better decision-making regarding either the extraction or addition
of new features.
The usual goal with feature selection is to find the minimal-optimal set of features, the feature
set that obtains the most relevant (optimal) classifier using the smallest possible number of features
[35]. Due to the importance of finding every feature related to the target variable, in some areas,
such as bioinformatics the goal is instead to find all of these relevant features. This constitutes the
all-relevant problem. Current literature focuses on these two formulations and in this thesis both
will be explored.
Feature selection is a complex problem as variables that have no information by themselves
can be relevant together and highly correlated variables still add information [34] and thus simply
ranking the feature may prove insufficient. Methods are commonly grouped by their learning
process into wrappers, filters and embedded methods which generate subsets and evaluate them
using machine learning models, filters, which perform the selection process before the model is
run and embedded methods which occur during the training process of a machine learning model
[34].
In the type of data which will be used in this thesis, genomic data, feature selection is a
particularly relevant area [34]. Since genomic datasets often consist of numerous features with
many of them redundant there is a wealth of knowledge to draw upon and there are methods
specifically implemented to solve problems in this area.
Boruta
Boruta is a feature selection algorithm based on the feature relevance comparison between the
original features and random added ones [36]. Random features are copied from existing ones
and then shuffled so that there is no correlation to the target variable. Afterwards the features
are ranked according to their gini impurity. Features score significantly higher than average vari-
able importance rating of the added random variables, plus a customizable threshold, are deemed
important and features that score significantly lower are discarded. The rest of the attributes are
considered to have undetermined importance and move to a new round. The process is repeated
until all attributes’ importance is determined or a set limit of rounds is reached.
Dimensionality Reduction
Dimensionality reduction methods condense the same amount of information in a smaller dataset.
They differ with feature selection methods in that feature selection operates on feature space by
removing or adding them but don’t remove features outright.
Principal Component Analysis
Principal Component Analysis (PCA) is the most common dimensionality reduction method and
it is frequently used in machine learning contexts anton PCA computes an orthogonal transfor-
mation of the original features into a using a different smaller set, called principal components,
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in a different coordinate system. This is done through the computation of the eigenvectors of the
feature spaces’ covariance matrix. The number of eigenvectors chosen determines the number of
new features, it is common to try to retain around 99% variance.
Machine Learning
Machine Learning (ML) algorithms will be used for the data mining section of the knowledge dis-
covery process. ML consists of allowing a machine to acquire information without being explicitly
programmed it allows for pattern recognition on large amounts through the use of a training set
with the results previously labeled or by data exploration if there is no training set. ML can be
used in a supervised learning context where we use a dataset with pre-calculated results to train the
model or unsupervised learning where the data is unlabeled. Supervised learning ML algorithms
deal with regression and classification problems. In regression the value of a continuous variable is
predicted whereas in classification problems we try to group objects into classes. In unsupervised
learning the most common problem is clustering that consists of grouping up similar objects. In
the following sections the algorithms planned to be used will be described.
Support Vector Machines
Support vector Machines (SVM) [37] are a supervised learning method that can be used for either
classification and regression. The model attempts to find the hyperplanes that best separate the
data. In order to be applied to cases where the data is not linearly separable the features of the
data must be transformed into a higher space however in this higher dimensional feature space
the calculations would be too computationally expensive. To solve this problem functions that
approximate the original calculations called kernel functions are often used. There are several
different types of kernel functions, the choice of which to use depends on the problem and is often
only found through experimentation. The versatility allowed by the different kernel functions and
the ability to deal with a high number of features make SVMs a commonly used machine learning
model.
Artificial Neural Networks
Artificial Neural Networks (ANN) [38] consist of an attempt at the emulation of the biological
networks of neurons present in the brain. The neural network consists of a set of parallel units,
usually called layers, that respond to a set of given inputs. Each unit in a layer receives an input or
a set of inputs and processes them into an output which is fed into a set of units in the next layer.
A neural network consists of an input and an output layer, with an optional amount of layers in be-
tween called the hidden layers. A network that has at least one hidden layer is called a multilayer
network [39]. The additional layers allow these networks to represent a wider range problems
besides linear ones. The function that processes the inputs of each unit the output is called the
activation function. There are many different activation functions, the more common ones are the
sigmoid function and the hyperbolic tangent.
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Supervised learning in neural networks is done by progressively updating the weights using the
difference of the output and the target multiplied by a user defined learning rate. In multilayer
networks a backpropagation method is commonly used. This method calculates the difference
between the output and the goal at every unit and calculates the new weight using a percentage of
gradient descent.
Decision Trees
Decision Trees (DT) [40] are a family of algorithms that classify the data through tree-like struc-
tures. The data is divided at decision points in the structure and leaf nodes represent the final
segments of the data. Decision trees are constructed by recursively using a greedy strategy that
divides the data according to a metric that varies between algorithms until a stopping criteria is
met. The most popular algorithms that use decision trees are C4.5 [41] and CART [42]. C4.5 is
an evolution of the ID3 algorithm and uses entropy as the metric to minimize at decision points.
CART uses Gini impurity instead and allows for regression along with classification.
Decision Trees have the main advantage of being a white-box model, which means we can inter-
pret the decisions made by the algorithm. Another of the advantages is that feature are individually
analyzed, this makes decision trees robust to non-centered and disparate features. In spite of this,
they are seldom used due to their high variance.
Ensemble Methods
Ensemble methods [43] combine various types of models in order to achieve better performance.
The use of an aggregate of multiple classifiers is done the robustness over a single instance of the
algorithm. To combine the various instances ensemble methods either average their predictions or
use the instances sequentially. To introduce randomness random subsets of the feature space and
are distributed by the various instances used, this process is used on some ensemble methods and
is called bagging. Some examples of ensemble methods are Adaboost [44] and Random Forests
[45].
Random Forests
Random Forests [45] are an ensemble method that uses decision trees as a base learner using
feature bagging. Each tree then votes for a model and the most popular one is chosen. Random
Forests can be used both for regression and classification. They retain the robustness to different
types of features from decision tress while removing the variance issues. This, with the additional
factor that random forests produce interpretable results, makes them a commonly used algorithm
in the context of cheminformatics. There are metrics associated with Random Forests that are
associated with feature importance. Gini impurity, used in classification trees, measures how
often a feature would correctly classify a random item. In regression problems the Residual Sum
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of Squares, which measures the difference between predicted and actual values is used to perform
splits and the mean squared error is used to measure feature importance instead.
Relational Algorithms
Relational machine learning algorithms are algorithms that take structured data such as graphs or
xml as input instead of a single data table. In this section two of the main approaches will be
explored.
Graph Mining
Graph Mining algorithms are a family of algorithms that try to find common substructures in a
graph. As molecules can be represented as graphs graph mining is often used in chemistry related
scenarios and because of that this family is of particular relevance to this project. The process of
graph mining can be divided in two main steps. The first step consists of finding the sub-graphs to
test for frequency and the second is the test of the frequency of the sub-graphs chosen.
Frequent Subgraph Mining
Frequent Subgraph Mining (FSM) attempts to find frequent graph structures in one or more graphs
[46]. Algorithms are categorized into either pattern growth algorithms or apriori-based. Apriori
algorithms are simpler but less efficient, they rely on joining graphs, starting with a single vertex,
and testing whether or not is it is frequent. Pattern growth approaches rely on extending an ex-
isting subgraph through edge addition. The most common applications are in bioinformatics as
molecules can easily be represented in graphs.
gSpan
gSpan is a frequent subgraph mining algorithm that follows a pattern growth approach [47]. The
gSpan algorithm starts by creating a unique representation of a graph, called a DFS code. First
each edge is assigned a code with the following format (x,y,z,i,j) where x is the starting vertex iden-
tifier, y the ending vertex identifier, z the vertex type, i the edge type and j the ending vertex type.
Then edges are ordered through a number of rules based on the assigned identifiers at the start, the
basic principle is that an edge connecting 2 vertexes cannot have the starting vertex higher than the
ending one with some exceptions for backwards edges and edge cases. To guarantee uniqueness
possible graph DFS codes can be compared and ordered and only the minimum set is chosen. The
ranking is done through a set of eleven rules with the general objective of minimizing backwards
edges. The second phase of the algorithm then expands from edges found in all the graphs where
the count is higher than the support level, which is the given frequency number for which we are
trying to find common subgraphs. It then extends the edge using a depth first search first trying
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to connect existing vertexes and after expanding the graph outwards checking the support level
and discarding if it’s not common enough. As the candidate graph is generated every subgraph is
pruned from future exploration or extension, since the search is depth-first a significant amount of
candidates can be pruned. An example of the output of the gSpan algorithm can be seen on List-
ing 2.1, an example of the input would simple the vertexes and edges, without the first and last line.
Listing 2.1: gSpan output example - the first line contains the id (8) and the number of times the
subgraph has been found. The following lines either vertexes following the ’v x y’ format x is the
id and y the atom type or the edges using the format ’e x y z’ where x is the starting vertex id, y
the ending vertex id and z the connection type. The last line contains references to the graph ID’s
in the input file where this subgraph was found
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Inductive Logic Programming
Inductive Logic Programming (ILP) [48] combines machine learning with logic programming.
ILP is a supervised learning method that requires that the background knowledge be encoded
as first-order logic rules and that a set of examples, either positive or negative, be given also
encoded as logic rules. ILP, as its name indicates uses inductive reasoning which generalizes
known examples to reach an hypothesis. An ILP algorithm usually consists of two phases. The first
is the generation of the candidate hypothesis and the second is the verification of the hypothesis
generated.
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ILP has been used with success in chemical problems [49]. The structure of a molecule can easily
be represented in first order logic rules with the ability to represent the connections between atoms
being of particular relevance. Another strength is the fact that ILP models output easily readable
rules.
Model Evaluation
Evaluating a model is an important part of the knowledge discovery process, it is necessary to know
what needs correcting and what the next steps should be. In order to avoid bias it is important to
construct separated training and testing sets. One common practice is to divide the labeled dataset
into a training set and a test set, this allows for the calculation of an error rate through the prediction
of the test set elements in the model previously trained in the training set. This simple method is
named Hold-Out validation. K-fold Cross Validation is a similar technique that divides the dataset
into k sets and each one of those sets take a turn being the test set while the other k-1 sets are used
as the training set.
Metrics
There are several metrics used in machine learning, with different ones being used in classification
or regression problems [50].
In classification metrics are based on the accuracy of the model. The simplest measure available
is accuracy, which is simple the division of the correct predictions by the number of cases in the
dataset. Precision and recall are two metrics that are often used together in classification prob-
lems; recall 2.1 measures the amount of positive examples out of all possible examples found and
precision 2.2 is the percentage of positive examples marked as such out of all positive examples
in the dataset. The F1 score 2.3 can be explained as a measure that takes both precision and recall













Another more complex metric commonly used is log-loss which requires the probability output of










yi, j log(pi, j) (2.4)
In regression the basic measurement is the sum of the differences between the correct values and
the predicted values. The most popular metric is the root mean square error which is described by










Another measure used is the median absolute percentage (MAPE) 2.6 which uses the median to
avoid the effect of outliers.
MAPE = median(|(ci− c¯i)/ci|) (2.6)
Also used in sciences is the Pearson correlation coefficient which measures correlation with 1
meaning total linear correlation, 0 no correlation and -1 negative correlation. With x and y meaning








There are many free and efficient implementations of the above machine learning algorithms.
Weka [51] is a software package developed in java by the University of Waikiti from New Zealand.
Weka contains pre-processing algorithms and all of the non relational algorithms mentioned above.
It is freely available for non commercial projects under the GPL 3.0 license.
Scikit-learn [52] is a python library that also provides the most common machine learning al-
gorithm. It is build on Python with Cython being used for some algorithms for efficiency reasons.
It is free to use under the BSD license. R [53] is programming language designed for statistical
problems. Machine Learning algorithms are available in the form of packages. Since its devel-
opment it has gained popularity as a data mining tool due to wide ranged of available algorithms
and its ease of use. R is freely available for non commercial products under the GNU General
Public license. The gSpan algorithm is available as an executable developed by the author at
https://www.cs.ucsb.edu/ xyan/software/gSpan.htm.
2.4 Related Work
Menden et al. [5] developed the first solutions for the prediction of IC50 values. Models were built
using as inputs biomarkers and copy number values from the cell tissue and 1 and 2 dimensional
descriptors with molecular fingerprints from drugs. Two dataset 8 fold splits were done, one
randomly and the other with no cell lines repeated acrros folds. Two models were then created
for each dataset, one with random forests and another with SVM’s both achieving 0.82 RMSE
predicting the IC50 values on the test fold having been trained on the rest of the folds and 0.96 on
a blind test set. This was a 20% increase in performance over non-machine learning methods.
In João Ladeiras’ dissertation [6] a similar cancel drug effectiveness model was built using
machine learning methods. The model was also based on a replication of Menden et al. and was
transformed into a classification problem and expanded with ILP and FSM. The replication results
were similar with 0.83 RMSE in the test fold and 0.93 in the test set. The models used were
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SVM’s, Random Forests and Neural Networks. After this parameter tuning was added having a
1% increase. After that a selection of gSpan features was added with no significant performance
increase. The problem transformed into a classification one and ILP also with no significant
performance increase. Costello et Al.[54] tested various algorithms for cancer drug prediction
on an NCI60 based dataset concluding that a novel algorithm, Bayesian multitask MKL, achieved
the highest performance. The evaluation metric used was a custom variant of the concordance
index, a common metric in survival analysis.
Iorio et al. [55] produced a model using the GDSC dataset and tumour derived cell lines from
eleven thousand patients. The paper introduced cancer functional events as predictors which were
defined as a collection of features that correlated positively with cancer existence in a cell lines.
Experiments were conducted using analysis of variance, machine learning algorithms and a novel
logical model named Logic optimization for binary input to continuous output (LOBICO) arriving
at a median Pearson correlation of 0.92 in pan-cancer models using as inputs cancer genes, focal
recurrently aberrant copy number segments and hypermethylated informative 5’C-phosphate-G-3’
sites in gene promoters. Machine learning models were also used to compare feature importances
with the conclusion that genomic features were the most important towards IC50 prediction.
Chapter 3
The methodology
In this chapter the methods and approach that were followed in the experiments are described.
First the dataset preprocessing and replication of Menden et al. [5] is detailed and following that
the experiments, including methods and reasoning. The experiments that were performed start
with the testing how the model responds to different amounts of data, following that the feature
space of the replication model is analyzed and the problem is transformed into a classification one.
The final experiment described is the addition of drug features obtained with Graph Mining to the
feature space.
3.1 Original Data
The base dataset that was utilized in our project is the 1.0 version of the Genomics of Drug Sensi-
tivity in Cancer (GDSC) project [56] 1. The dataset contains IC50 values, cell line characterization
and other information for 638 cell lines and 136 drugs. Only 58% of drug-cell line pairs have IC50
values with remaining pairs being blank. The 1.1 version added 15,578 cell/drug pairs, these were
used to build an additional blind test set.
In addition to the base GDSC data, generated drug features, obtained using the PaDEL soft-
ware, were also added to the dataset. These features will be detailed in the following sections.
3.1.1 Genomic Features
Each cell line is characterized by 155 genomic features – the genetic mutation data consists of the
Microsatellite instability (MSI) status, the coding variant and copy number variation for 68 tissue
biomarkers making a total of 137 features. The features are encoded in the dataset as follows:
• MSI status is 1 if unstable and 0 if stable.
• The phenotype and copy number are put together in an object with the "X::Y" form where




Figure 3.1: IC50 Values Histogram
• The coding variant is either "wt" (wildtype) or a mutation which starts with "p."
• The copy number is either ">=8" (amplification), "0" (deletion) or "0<cn<8" (wildtype)
To simplify the features for machine learning purposes, the copy number and coding variant
were transformed into numerals through the following rules:
• The coding variant is 0 if it’s wildtype or 1 if it’s a mutation.
• The copy number is 0 if it’s wildtype, 1 if an amplification and -1 if it’s a deletion.
3.1.2 Drug Features
For the 110 drugs for which there were a SMiLEs string available, it was obtained using the
PubChem API. Using the SMiLES string and PaDEL version 2.11 the 1D and 2D descriptors and
molecular fingerprints were obtained. Some examples of features are the number of times each
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atom is found, topological graph indexes (Zagreb Index) and for the fingerprints - the existence
or not of an N-N bond. The total number of drug features is 1603 with 722 being 1D and 2D
descriptors and 881 molecular fingerprints.
3.2 Data Preprocessing
The steps taken by Menden et al. [5] were used as a reference as those are the results we replicate
as a basis. The data was organized as cell line/drug pairs each having an IC50 value, pairs that did
not have an IC50 were dropped leaving a total of 38,654 pairs left.
Genomic features with more than 15 missing genomic values were removed, which resulted
in the deletion of 61 cell lines. Every feature with missing values was removed. For the drug
features all of those with missing values were removed. The final dataset consists of 790 total
features of 38654 drug/cell pairs and 15578 extra testing pairs. The full list of features is available
on appendix A.
The results of the preprocessing were similar to Menden et al. but not equal, the final result for
the preprocessing was 790 features in our case and in the original paper it was 827. These results
can be explained by difference in software versions such as PADeL or unclear procedures in the
original paper, a full list of features is not provided so there can be no confirmation of what extra
features were removed. Ladeiras arrived at the number of 932 features, which further corroborates
the unclarity of the procedures in Menden et al. For the rest of this document the test fold will be
the left-out fold in cross validation, the train set the folds used to train the model and the test set
the 15,768 extra pairs in the 1.1 version.
3.3 Replication of Menden et al. random forests experiment
The first experiment is replicating Mendel et Al’s [5] random forests model in order to use the
results as a baseline. As in the original experiment, the dataset is separated into 8 folds with 1 left
out for testing and with no parameter training performed. 2000 trees were used, since no number
is given. The relatively high number serves to err on the side of caution. The model is built using
the R language with the ’randomForest’ package using 2000 decision trees. The results can be
seen in the next chapter in Table 4.1.
3.4 Experiments
The methodology for the experiments performed after the replication of the original study are de-
scribed in the following sections. A significant body of literature [57]–[59] provides solid evidence
that improving the feature space is more relevant to better model creation than the algorithm used.
This influenced the choice of the experiments done, no changes to the algorithm were made and
the focus was on adding or improving existing features. At the start we performed a learning curve
and analyze how the model performs under different amounts of data, after that the performance
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of the different types of features are analyzed and finally we explore the addition of Graph Mining
features. The results are presented and discussed in Chapter 4.
3.5 Learning curve analysis
In order to better understand the behavior of the model when given different amounts of data,
the previous experiment was repeated while withholding certain data percentages on the left-out
fold and on the 1.1 test set. Also added was the result of evaluating the model on the same data
it was trained on in order to evaluate over-fitting. We fed the model different amounts of data
in steps of 20%, ending with the percentages of 20, 40, 60, 80. We also add 2% to this list to
have an initial low value. Understanding this behavior is highly relevant in the context of cell line
experiments, as those experiments are cumbersome to perform, therefore evaluating whether more
examples correlate with a a better model using the same features is valuable. In addition, despite
the simplicity of the learning curve, the method has never been applied regarding this dataset
which also adds value to this approach.
3.6 Feature Selection
Understanding how the features affect a machine learning model is key for it’s improvement. There
are several insights that can be gained from this – which features provide the most information gain
between genomic cell line information and drug features and also among their subcategories. This
can enable the removal of irrelevant features or to direct research and improvements towards them.
In order to do this metrics produced by the random forests will be analyzed, these measure the
averaged MSE and node purity, the first is a feature importance rating following the methodology
for these in the previous chapter, the second indicates how well the data is split by that feature.
These are included in the randomForests R package which was used to build the model. In addition
the Boruta [36] feature selection algorithm was ran to compare features against random noise and
classify them either useful or not. A limit of 100 rounds, the default value, was imposed on Boruta
due to time constraints.
3.7 Classification
After the regression analysis the problem was transformed into a classification one so as to explore
it’s performance in a different type of model, if it’s easier to classify cell-drug pairs as having a
strong reaction or not and if those categories provide an accurate enough reaction description. The
categorization of drug-cell IC50 reaction are as follows:
• Lower than 1.3 IC50 was coded as -1
• Between 1.3 and 1.5 IC50 was coded as 0
• Higher than 1.5 IC50 was coded as 1
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This is based on the IC50 histogram in Figure 3.1. After this the first random forests experiment
was repeated using 128 trees and 4 folds. The reduced number of folds and trees is due to time
constraints.
3.8 Frequent Subgraph Mining
Graph Mining was used to help in unveiling common substructures of the applied drug that could
help domain experts explain it’s effect on the cell lines. The possibility of characterizing the
drugs with their molecular substructures, adding them to the remaining features, was explored.
In order to find the substructures the drugs were represented as graphs and Frequent Subgraph
Mining algorithms were ran. This shares some similarities with the molecular fingerprints, the
goal is to find out whether by creating a tailored feature set for the drugs present in the dataset the
fingerprints can be outperformed and also to evaluate the performance of the approach in general.
The algorithm chosen was for Frequent Subgraph Mining was gSpan [47], due to it’s per-
formance and availability. The implementation used was the 64-bit original executable 2. The
algorithm was ran with a support level of 20%. The FSM ecosystem does not have readily avail-
able converters so custom solutions were used. To convert the data from the sdf format to gSpan
a tool by Andreas Maunz[60] was used. GSpan results were then converted to per graph columns
were 1 indicates the presence of the subgraph in the drug and 0 the fact that it is not present. This
resulted in the addition of 919 features top to the dataset resulting in 1710 total features.
Two experiments were ran, first a replication of the first one with 2000 trees and 8 folds and
another one where the features were considered factors with a reduced number of trees – 64 and
only 4 folds; This is because with the full gSpan dataset each tree takes around an hour to be
processed. The low number of trees may have some impact on performance but Ladeiras ran
similar experiments with lower tree numbers with no significant performance reduction.
2Available at https://www.cs.ucsb.edu/ xyan/software/gSpan.htm
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Chapter 4
Discussion of the Results
In this chapter we present the results, starting with the replication of the Menden et al. ’s experi-
ment [5] and moving on to the learning curve, feature selection and FSM features discussing the
results in the context of the problem.
4.1 Replication of the original study
The results indicate a successful replication of Menden et al. ’s experiment, the RMSE was 0.82
in the validation fold while our result was 0.83. The small difference can be explained by the
difference in features described in the previous section. The RMSE on the blind test set was 0.98
also similar to the 0.97 in Menden et al., about 5% higher than the result Ladeiras’ model [6] had
in the same experiment (0.92), this can be explained by the differences in data preprocessing and
in decision tree number. It can be concluded that the results are similar, even tough there were
some discrepancies in the feature sets, the similarity in results allows the model to be used as a
baseline for future experiments.
Table 4.1: Per fold results of the replication of Menden et al. random forests with the Root Mean











Std Dev 0.0125 0.109
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Figure 4.1: Line plot of the results of the prediction on the left-out validation fold (blue), the
version 1.1 test set (yellow) and train set (red)
4.2 Learning Curve
The results of the learning curve, in which the model was fed different amounts of data, can be
seen on Figure 4.1 and the full results are available on Appendix B.
The main takeaway is that no significant gains are had with higher amounts of data, even with
20% of the data used the results are similar to when the full dataset is used. This indicates that
priority should be given to either improving the models or the feature set. The performance of the
model is higher in the train set which can indicate overfitting. Further corroborating this is the
fact that the blind test set, which contains different cell line pairs has worse performance. Despite
this when more data is added there is no performance loss, which shows that it’s not a problematic
case.
4.3 Feature Selection
The results of the Boruta algorithm regarding confirmed or rejected features can be seen on Table
4.2 with the full results available on Appendix C. From the 790 total features 178 were confirmed,
446 rejected and 176 were left uncategorized due to the 100 round run limit.
Table 4.2: Boruta rejected and confirmed features
Genomic Molecular 1 and 2D Molecular Fingerprints Total
Rejected 91 25 329 445
Confirmed 13 126 39 178
Tentative 2 4 161 167
Total 106 155 529 790
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Even though the 100 run limit was imposed, most features were categorized by the Boruta al-
gorithm, while taking 1 week to run on a 4 core modern CPU computer, therefore we can conclude
that the round limit was a reasonable choice. The first conclusion drawn from the results is that a
significant amount of features are low quality and perform no better than random noise. Molecular
1 and 2D descriptors performed consistently with almost all of them being considered relevant.
The molecular fingerprints and Genomic features performed rather poorly with only 7% and 13%,
respectively, being considered relevant.
To complete our feature analysis we can also see the results of the built in average MSE feature
ranking and node purity by the randomforest package on Figure 4.2. These results indicate the The
full importance results for one fold can be visualized on Appendix E. The results shown are for
one fold only, but all of the folds exhibit the same behaviour. It is possible to see that the features
with the most information gain were genomic ones. This can be explained by the fact that this is a
pan-cancer model, and the model is more tuned to a particular type of cancer the features for which
have a high amount of information, while other similarly typed cell line features end up having
lower contributions. There is no information about cancer type in this version of the dataset. This
is consistent with Iorio et al. where cancer specific models had better performance. Molecular
1D and 2D features provide consistent information gain but do not rank very high, showing they
are consistent but not overly important. Even though the feature sets were different, especially in
the cell line information, gene expression features, represented here by the phenotype (wildtype),
were the most important features in an experiment conducted with Random Forests by Iorio et al.
which is also consistent with the findings here.
4.4 Classification
The results of the averaged 4-fold classification can be seen on Tables 4.3, 4.4 and 4.5. The
results of the 0 class were omitted since its prevalence was around 5% which makes the results too
disparate. In hindsight it would have been preferable to either remove the class or expand the 1 or
-1 classes.
It can be concluded that the results prove that this transformation is at least viable with good
accuracy results. Comparing to Ladeiras our results show worse performance in precision and
recall, for example in validation fold precision and recall are 0.9 in Ladeiras’ version while we
achieved 0.8 and 0.7, respectively. The difference in features - described in the replication results
can account for some of the differences with the rest being due to a difference class split.
Table 4.3: Classification accuracy on the validation fold and set
validation fold Test Set
Accuracy 0.7836 0.769
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Figure 4.2: Random Forest importance for the first fold in the first experiment
4.5 gSpan
The random forest experiment was reran with the same parameters as the first experiment with the
results seen on Table 4.6 and also with gSpan features as a factor in Table 4.7. The results on the
test set were the same to two decimal places – 0.98 RMSE. There was no significant improvement
and the results are mostly similar.
Through the analysis of the importance scores produced by the random forests model, from
which the top 30 features can be seen in Figure 4.3 with the rest available in Appendix D, it is
indeed possible to see that the average MSE of these features is quite low – 3.3, with the genomic
features having, as an example, 22 average MSE even though some of them are negative and
the number 1 ranked feature having 120 average MSE. The molecular fingerprints features had an
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Table 4.4: Classification values on class 1 and -1 on the validation fold
Precision Recall F1
1 0.83 0.78 0.80
-1 0.82 0.769 0.79
average MSE of 3.12, which means that the added gSpan features had a higher overall importance.
In short the prevalence of the cell line features has eclipsed the results of other features, including
the gSpan ones that were added. This is also consistent with the results obtained by Ladeiras in a
similar experiment also with gSpan features, though they were heavily preprocessed.
4.6 Final result analysis
Reviewing all the tests there are significant conclusions to be had, the first ones relate to the model
itself; The learning curve shows the model doesn’t improve with more data and the Boruta algo-
rithm and feature importance ratings show that a significant number of features are not superior
to noise. This shows that there is room for improvement in the original model, improving the fea-
tures may resolve the behavior seen in the learning curve. Drug features, though more numerous
contributed significantly less to the model than cell line ones, which indicates that the addition of
more characterization of the cell lines could yield better results. Recent research has been in this
direction[55] further corroborating the conclusion.
Regarding gSpan features, they are still an interesting exploration pursuit even though the
results weren’t particularly encouraging. The experiment performed allowed for an evaluation of
the importance of most FSM features since no features were removed. In the end they ended being
drowned by other features, particularly genomic ones.
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Table 4.5: Classification values on class 1 and -1 on the test set
Precision Recall F1
1 0.85 0.77 0.81
-1 0.79 0.75 0.75
Table 4.6: Per fold results of the replication of Menden et al. random forests with the addition of











Std Dev 0.0125 0.011
Table 4.7: Per fold results of the replication of Menden et al. random forests with added gSpan







Std Dev 0,01 0,006
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Figure 4.3: Random Forest importance for the first fold in the gSpan experiment
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Chapter 5
Conclusions and Future Work
In this chapter the overall goal satisfaction and future work possibilities are explored.
5.1 Goal Satisfaction
The goal of gaining insight and providing solutions to improve model performance was mostly
achieved. The learning curve will help inform future decisions regarding dataset expansion and
the application of frequent subgraph mining in this problem in this form was novel in spite of
non-stellar results. The main limitation factor throughout this project was the time required for
the model to be trained on the available machines, nevertheless the analysis that was performed is
valuable for future approaches to the problem and can be generalized to future approaches in this
problem. Perhaps the biggest shortcoming in the project was sticking too closely to Menden et al.
’s model, developing different metrics and using different datasets so as to able to better compare
against other studies.
5.2 Future Work
Since the run time of the experiments was quite high some possibilities were not explored and
thus there are a number of possible paths regarding future work. Regarding the gSpan experi-
ments there are interesting possibilities to try. Removing the molecular fingerprints after adding
the gSpan features could produce better results since there is some redundancy regarding finger-
prints and gSpan features. Another possibility is removing all gSpan features that are present
in all drugs under a certain threshold. Those molecular substructures may be too common too
characterize a drug and may be only adding noise reducing overall performance. Experimenting
with different support levels in the gSpan algorithm or trying different FSM algorithms altogether
would also be a worthwhile pursuit. Exploring the use of deep learning in this particular problem
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Feature Name Feature Name Feature Name Feature Name
MS-HL AKT2_cn ALK_wt APC_wt
APC_cn BRAF_wt BRAF_cn BRCA1_wt
BRCA2_wt BRCA2_cn CCND1_cn CCND2_cn
CCND3_cn CDH1_wt CDH1_cn CDK4_cn
CDK6_cn CDKN2A_wt CDKN2A_cn CDKN2C_wt
CDKN2C_cn CDKN2a(p14)_wt CTNNB1_wt CTNNB1_cn
CYLD_wt EGFR_wt EGFR_cn EP300_cn
ERBB2_wt ERBB2_cn EZH2_wt EZH2_cn
FAM123B_wt FAM123B_cn FBXW7_wt FBXW7_cn
FGFR2_cn FGFR3_wt FGFR3_cn FLCN_wt
FLT3_wt FLT3_cn GNAS_wt GNAS_cn
HRAS_wt IDH1_wt IDH1_cn JAK2_wt
JAK2_cn KDM5C_wt KDM5C_cn KDM6A_wt
KDM6A_cn KDR_cn KIT_cn KRAS_wt
KRAS_cn MAP2K4_wt MAP2K4_cn MDM2_cn
MET_cn MLH1_wt MLH1_cn MLLT3_cn
MSH2_wt MSH2_cn MSH6_wt MSH6_cn
MYC_cn MYCL1_cn MYCN_cn NF1_wt
NF1_cn NF2_wt NF2_cn NOTCH1_wt
NRAS_wt NRAS_cn PDGFRA_cn PIK3CA_wt
PIK3CA_cn PIK3R1_wt PIK3R1_cn PTEN_wt
PTEN_cn RB1_wt RB1_cn RUNX1_wt
SETD2_wt SMAD4_wt SMAD4_cn SMARCA4_wt
SMARCA4_cn SMARCB1_cn SMO_cn SOCS1_cn
STK11_wt STK11_cn TET2_wt TP53_wt
TP53_cn TSC1_wt TSC1_cn VHL_wt
VHL_cn WT1_cn PubchemFP0 PubchemFP1
PubchemFP2 PubchemFP6 PubchemFP9 PubchemFP10
PubchemFP11 PubchemFP12 PubchemFP13 PubchemFP14
PubchemFP15 PubchemFP16 PubchemFP17 PubchemFP18
PubchemFP19 PubchemFP20 PubchemFP21 PubchemFP22
PubchemFP23 PubchemFP24 PubchemFP25 PubchemFP30
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PubchemFP33 PubchemFP34 PubchemFP37 PubchemFP38
PubchemFP43 PubchemFP44 PubchemFP46 PubchemFP93
PubchemFP115 PubchemFP116 PubchemFP117 PubchemFP118
PubchemFP129 PubchemFP130 PubchemFP132 PubchemFP143
PubchemFP144 PubchemFP145 PubchemFP146 PubchemFP147
PubchemFP148 PubchemFP149 PubchemFP150 PubchemFP152
PubchemFP153 PubchemFP155 PubchemFP156 PubchemFP157
PubchemFP159 PubchemFP160 PubchemFP164 PubchemFP167
PubchemFP178 PubchemFP179 PubchemFP180 PubchemFP181
PubchemFP182 PubchemFP183 PubchemFP184 PubchemFP185
PubchemFP186 PubchemFP187 PubchemFP188 PubchemFP189
PubchemFP190 PubchemFP191 PubchemFP192 PubchemFP193
PubchemFP194 PubchemFP195 PubchemFP199 PubchemFP200
PubchemFP206 PubchemFP213 PubchemFP214 PubchemFP218
PubchemFP219 PubchemFP227 PubchemFP228 PubchemFP232
PubchemFP233 PubchemFP241 PubchemFP246 PubchemFP247
PubchemFP248 PubchemFP252 PubchemFP255 PubchemFP256
PubchemFP257 PubchemFP258 PubchemFP259 PubchemFP260
PubchemFP261 PubchemFP262 PubchemFP274 PubchemFP294
PubchemFP297 PubchemFP298 PubchemFP299 PubchemFP300
PubchemFP301 PubchemFP305 PubchemFP308 PubchemFP314
PubchemFP327 PubchemFP328 PubchemFP330 PubchemFP332
PubchemFP333 PubchemFP334 PubchemFP335 PubchemFP336
PubchemFP337 PubchemFP338 PubchemFP339 PubchemFP340
PubchemFP341 PubchemFP342 PubchemFP344 PubchemFP345
PubchemFP346 PubchemFP347 PubchemFP349 PubchemFP350
PubchemFP351 PubchemFP352 PubchemFP353 PubchemFP355
PubchemFP356 PubchemFP357 PubchemFP358 PubchemFP359
PubchemFP360 PubchemFP362 PubchemFP363 PubchemFP364
PubchemFP365 PubchemFP366 PubchemFP367 PubchemFP368
PubchemFP370 PubchemFP371 PubchemFP372 PubchemFP373
PubchemFP374 PubchemFP375 PubchemFP376 PubchemFP377
PubchemFP378 PubchemFP379 PubchemFP380 PubchemFP381
PubchemFP382 PubchemFP383 PubchemFP384 PubchemFP385
PubchemFP386 PubchemFP387 PubchemFP388 PubchemFP389
PubchemFP390 PubchemFP391 PubchemFP392 PubchemFP393
PubchemFP394 PubchemFP395 PubchemFP396 PubchemFP397
PubchemFP398 PubchemFP399 PubchemFP400 PubchemFP403
PubchemFP404 PubchemFP405 PubchemFP406 PubchemFP407
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PubchemFP584 PubchemFP585 PubchemFP586 PubchemFP588
PubchemFP589 PubchemFP591 PubchemFP592 PubchemFP593
PubchemFP594 PubchemFP595 PubchemFP596 PubchemFP597
PubchemFP598 PubchemFP599 PubchemFP600 PubchemFP601
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PubchemFP606 PubchemFP607 PubchemFP608 PubchemFP609
PubchemFP610 PubchemFP611 PubchemFP612 PubchemFP613
PubchemFP614 PubchemFP615 PubchemFP616 PubchemFP618
PubchemFP619 PubchemFP620 PubchemFP621 PubchemFP622
PubchemFP623 PubchemFP624 PubchemFP625 PubchemFP626
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PubchemFP683 PubchemFP684 PubchemFP685 PubchemFP686
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PubchemFP729 PubchemFP733 PubchemFP734 PubchemFP735
PubchemFP736 PubchemFP737 PubchemFP738 PubchemFP740
PubchemFP742 PubchemFP743 PubchemFP745 PubchemFP746
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PubchemFP758 PubchemFP759 PubchemFP761 PubchemFP762
PubchemFP763 PubchemFP764 PubchemFP766 PubchemFP767
PubchemFP770 PubchemFP771 PubchemFP772 PubchemFP776
PubchemFP777 PubchemFP778 PubchemFP779 PubchemFP780
PubchemFP782 PubchemFP784 PubchemFP785 PubchemFP788
PubchemFP791 PubchemFP792 PubchemFP796 PubchemFP797
PubchemFP798 PubchemFP799 PubchemFP800 PubchemFP801
PubchemFP803 PubchemFP805 PubchemFP806 PubchemFP808
PubchemFP809 PubchemFP810 PubchemFP812 PubchemFP813
PubchemFP814 PubchemFP815 PubchemFP818 PubchemFP819
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PubchemFP825 PubchemFP826 PubchemFP827 PubchemFP829
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nAcid apol naAromAtom nAromBond
nAtom nHeavyAtom nH nB
nC nN nO nS
nP nF nCl nBr
nI ATSc1 ATSc2 ATSc3
ATSc4 ATSc5 ATSm1 ATSm2
ATSm3 ATSm4 ATSm5 ATSp1
ATSp2 ATSp3 ATSp4 ATSp5
nBase nBonds nBonds2 nBondsS
nBondsS2 nBondsS3 nBondsD nBondsD2
nBondsT bpol C1SP1 C2SP1
C1SP2 C2SP2 C3SP2 C1SP3
C2SP3 C3SP3 C4SP3 SCH-3
SCH-4 SCH-5 SCH-6 SCH-7
VCH-3 VCH-4 VCH-5 VCH-6
VCH-7 SC-3 SC-4 SC-5
SC-6 VC-3 VC-4 VC-5
VC-6 SPC-4 SPC-5 SPC-6
VPC-4 VPC-5 VPC-6 ECCEN
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fragC nHBAcc nHBAcc2 nHBAcc3
nHBAcc_Lipinski nHBDon nHBDon_Lipinski nAtomLC
nAtomP nAtomLAC MLogP McGowan_Volume
MDEC-11 MDEC-12 MDEC-13 MDEC-14
MDEC-22 MDEC-23 MDEC-24 MDEC-33
MDEC-34 MDEC-44 MDEO-11 MDEO-12
MDEO-22 MDEN-11 MDEN-12 MDEN-13
MDEN-22 MDEN-23 MDEN-33 MLFER_A
MLFER_BH MLFER_BO MLFER_S MLFER_E
MLFER_L PetitjeanNumber nRing n3Ring
n4Ring n5Ring n6Ring n7Ring
n8Ring n9Ring n10Ring nG12Ring
nFRing nF6Ring nF8Ring nF9Ring
nF10Ring nF11Ring nF12Ring nFG12Ring
nTRing nT4Ring nT5Ring nT6Ring
nT7Ring nT8Ring nT9Ring nT10Ring
nT11Ring nT12Ring nTG12Ring nRotB
TopoPSA VAdjMat MW WTPT-1
WTPT-2 WTPT-3 WTPT-4 WTPT-5
WPATH WPOL Zagreb





Test Fold Train Set Test Set
RMSE R^2 RMSE R^2 RMSE R^2
1 0,966 0,642 0,466 0,916 1,034 0,584
2 0,833 0,693 0,484 0,91 1,035 0,593
3 0,987 0,589 0,475 0,914 1,037 0,594
4 1,033 0,518 0,457 0,921 1,043 0,586
5 0,929 0,68 0,467 0,915 1,02 0,6
6 0,892 0,721 0,48 0,91 1,03 0,591
7 0,903 0,684 0,48 0,91 1,034 0,589
8 0,87 0,713 0,48 0,911 1,02 0,6
AVG 0,934714286 0,646714286 0,472714286 0,913714286 1,033285714 0,591
Table B.1: Per fold RMSE and R squared results for 2% of the dataset
20%
Test Fold Train Set Test Set
RMSE R^2 RMSE R^2 RMSE R^2
1 0,829 0,723 0,502 0,896 0,989 0,62
2 0,827 0,711 0,504 0,896 0,997 0,616
3 0,877 0,676 0,491 0,901 0,993 0,618
4 0,858 0,704 0,497 0,898 0,995 0,618
5 0,865 0,685 0,501 0,897 0,922 0,621
6 0,845 0,696 0,503 0,896 0,922 0,619
7 0,86 0,694 0,5 0,897 0,989 0,622
8 0,828 0,706 0,501 0,897 0,992 0,619
AVG 0,851571429 0,698428571 0,499714286 0,897285714 0,972428571 0,619142857
Table B.2: Per fold RMSE and R squared results for 20% of the dataset
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40%
Test Fold Train Set Test Set
RMSE R^2 RMSE R^2 RMSE R^2
1 0,84 0,704 0,534 0,881 0,993 0,614
2 0,842 0,704 0,531 0,881 0,99 0,616
3 0,835 0,712 0,526 0,884 0,992 0,615
4 0,826 0,709 0,532 0,882 0,992 0,614
5 0,862 0,677 0,526 0,884 0,989 0,617
6 0,822 0,723 0,529 0,882 0,99 0,616
7 0,857 0,693 0,529 0,883 0,991 0,615
8 0,848 0,685 0,527 0,884 0,99 0,616
AVG 0,840571429 0,703142857 0,529571429 0,882428571 0,991 0,615285714
Table B.3: Per fold RMSE and R squared results for 40% of the dataset
60%
Test Fold Train Set Test Set
RMSE R^2 RMSE R^2 RMSE R^2
1 0,82 0,719 0,542 0,878 0,99 0,618
2 0,857 0,703 0,549 0,878 0,992 0,617
3 0,849 0,695 0,54 0,879 0,991 0,618
4 0,832 0,7 0,542 0,878 0,991 0,617
5 0,835 0,713 0,54 0,878 0,986 0,62
6 0,84 0,705 0,54 0,879 0,993 0,616
7 0,816 0,718 0,544 0,877 0,986 0,621
8 0,824 0,709 0,541 0,879 0,986 0,62
AVG 0,835571429 0,707571429 0,542428571 0,878142857 0,989857143 0,618142857
Table B.4: Per fold RMSE and R squared results for 60% of the dataset
80%
Test Fold Train Set Test Set
RMSE R^2 RMSE R^2 RMSE R^2
1 0,84 0,704 0,554 0,872 0,987 0,618
2 0,841 0,704 0,55 0,874 0,987 0,618
3 0,834 0,712 0,553 0,872 0,988 0,618
4 0,849 0,7 0,552 0,873 0,99 0,616
5 0,806 0,71 0,557 0,872 0,984 0,621
6 0,833 0,713 0,553 0,872 0,987 0,62
7 0,839 0,704 0,552 0,873 0,989 0,618
8 0,829 0,711 0,553 0,873 0,987 0,619
AVG 0,834571429 0,706714286 0,553 0,872571429 0,987428571 0,618428571
Table B.5: Per fold RMSE and R squared results for 80% of the dataset
Appendix C
Boruta Results
Feature Name meanImp medianImp minImp maxImp normHits decision
MS.HL 0,56 0,6 -1,17 2,36 0 Rejected
AKT2_cn 0,56 0,29 -1 2,3 0 Rejected
ALK_wt 0,86 0,95 -1,42 2,48 0 Rejected
APC_wt 7,64 7,6 5,14 9,59 1 Confirmed
APC_cn 1,03 1,4 -0,93 2,07 0 Rejected
BRAF_wt 16,76 16,9 13,77 19,9 1 Confirmed
BRAF_cn -0,57 -0,69 -3,64 2,14 0 Rejected
BRCA1_wt 1,75 1,74 0 3,37 0 Rejected
BRCA2_wt 0,91 1,03 -1,14 2,35 0 Rejected
BRCA2_cn 0,55 0,75 -0,93 1,6 0 Rejected
CCND1_cn 1,82 1,84 -0,34 3,56 0,01010101 Rejected
CCND2_cn 2,49 2,43 1,22 4,01 0 Rejected
CCND3_cn -1,43 -1,46 -3,73 0,17 0 Rejected
CDH1_wt -0,74 -0,61 -2,83 1,52 0 Rejected
CDH1_cn 1,91 2 0,5 3,18 0 Rejected
CDK4_cn 0,88 0,83 -0,66 2,76 0 Rejected
CDK6_cn -0,58 -0,7 -2 1,38 0 Rejected
CDKN2A_wt 13,93 14 10,74 16,15 1 Confirmed
CDKN2A_cn 12,24 12,36 9,45 14,2 1 Confirmed
CDKN2C_wt -0,78 -1,01 -2,48 2,23 0 Rejected
CDKN2C_cn -0,65 -0,89 -2,23 1,33 0 Rejected
CDKN2a.p14._wt 13,26 13,24 10,6 15,13 1 Confirmed
CTNNB1_wt -0,12 -0,23 -1,57 1,62 0 Rejected
CTNNB1_cn -0,02 -0,1 -2,8 1,85 0 Rejected
CYLD_wt 0,72 0,99 -1,01 2,05 0 Rejected
EGFR_wt -0,72 -0,73 -2,21 1,64 0 Rejected
EGFR_cn -0,79 -0,74 -2,03 0,29 0 Rejected
EP300_cn 0,47 0,56 -2,2 1,7 0 Rejected
ERBB2_wt 0,7 0,69 -0,63 1,83 0 Rejected
ERBB2_cn 7,11 7,11 4,82 9,34 1 Confirmed
EZH2_wt -0,51 -0,43 -2,31 0,73 0 Rejected
EZH2_cn -0,45 -0,45 -2,08 0,92 0 Rejected
FAM123B_wt 3,41 3,48 1,65 5,43 0,535353535 Tentative
FAM123B_cn 1,77 1,79 -0,44 2,71 0 Rejected
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FBXW7_wt 0,06 -0,05 -2,3 1,86 0 Rejected
FBXW7_cn 1,11 1,38 -0,6 2,68 0 Rejected
FGFR2_cn 2,78 2,92 0,99 4,49 0,090909091 Rejected
FGFR3_wt 1,75 1,81 0,54 2,6 0 Rejected
FGFR3_cn 1,73 1,72 -0,18 2,91 0 Rejected
FLCN_wt 1,02 0,92 -0,49 2,48 0 Rejected
FLT3_wt 1,12 1,13 -1,46 2,55 0 Rejected
FLT3_cn 0 -0,22 -1,62 1,75 0 Rejected
GNAS_wt 1,47 1,33 0,39 2,74 0 Rejected
GNAS_cn 0,73 0,49 -0,92 2,39 0 Rejected
HRAS_wt -1,89 -1,92 -4,05 0,43 0 Rejected
IDH1_wt 1,18 1,45 -0,53 2,47 0 Rejected
IDH1_cn 0,87 1,12 -0,8 2,24 0 Rejected
JAK2_wt 1,26 1,27 -0,23 2,37 0 Rejected
JAK2_cn 0,29 0,11 -1,48 2,23 0 Rejected
KDM5C_wt -0,37 -0,29 -2,04 1,92 0 Rejected
KDM5C_cn -0,01 0 -1,4 1,38 0 Rejected
KDM6A_wt -0,17 -0,22 -1,62 1,86 0 Rejected
KDM6A_cn -1,03 -1,02 -2,58 0,43 0 Rejected
KDR_cn 0,87 0,91 -1,17 2,85 0 Rejected
KIT_cn 0,71 0,59 -0,98 1,92 0 Rejected
KRAS_wt 6,76 6,8 4,7 9,2 1 Confirmed
KRAS_cn 0,2 0,4 -1,14 1,05 0 Rejected
MAP2K4_wt 0,14 -0,08 -1,16 2,07 0 Rejected
MAP2K4_cn -0,31 -0,26 -2,19 1,8 0 Rejected
MDM2_cn 2,18 2,26 0,83 3,41 0 Rejected
MET_cn 0,95 0,94 -0,52 2,36 0 Rejected
MLH1_wt 1,93 1,75 0,03 4,29 0,01010101 Rejected
MLH1_cn 1,55 1,9 -0,93 2,88 0 Rejected
MLLT3_cn 0,96 1,03 -0,92 2,86 0 Rejected
MSH2_wt -1,72 -1,94 -3,66 0,6 0 Rejected
MSH2_cn -1,37 -1,39 -3,06 0,31 0 Rejected
MSH6_wt -1,38 -1,4 -2,69 0,04 0 Rejected
MSH6_cn 0,71 1,02 -1,97 1,92 0 Rejected
MYC_cn 0,63 0,78 -1,36 1,92 0 Rejected
MYCL1_cn -0,15 -0,31 -1,92 1,39 0 Rejected
MYCN_cn 7,79 7,79 6,26 10,16 1 Confirmed
NF1_wt -0,54 -0,41 -2,84 0,89 0 Rejected
NF1_cn 0,37 0,66 -1,17 1,82 0 Rejected
NF2_wt 2,46 2,36 -0,01 4,16 0,02020202 Rejected
NF2_cn -0,34 -0,2 -2,04 1,42 0 Rejected
NOTCH1_wt 3,85 3,67 0,76 8,05 0,585858586 Tentative
NRAS_wt 4,24 4,27 1,32 6,92 0,747474747 Confirmed
NRAS_cn 1,13 1,21 -0,3 2,76 0 Rejected
PDGFRA_cn 0,96 0,89 -1,64 2,85 0 Rejected
PIK3CA_wt 1,91 1,86 0,75 3,01 0 Rejected
PIK3CA_cn 0,69 0,43 -1 3,36 0 Rejected
PIK3R1_wt 1,41 1,57 -0,06 2,51 0 Rejected
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PIK3R1_cn 2,63 2,49 0,74 4,8 0,131313131 Rejected
PTEN_wt 1,94 1,6 0,86 4,03 0 Rejected
PTEN_cn 1,51 1,61 -0,41 2,94 0 Rejected
RB1_wt 5,08 5,1 2,61 7,46 0,898989899 Confirmed
RB1_cn -0,37 -0,24 -1,7 1,24 0 Rejected
RUNX1_wt 0,63 0,67 -0,54 2,03 0 Rejected
SETD2_wt -0,41 -0,36 -2,12 2,33 0 Rejected
SMAD4_wt 6,89 6,86 4,05 9,19 1 Confirmed
SMAD4_cn 0,64 0,96 -0,62 2,41 0 Rejected
SMARCA4_wt 0,63 0,54 -0,89 2,48 0 Rejected
SMARCA4_cn 0,51 0,78 -1 1,5 0 Rejected
SMARCB1_cn 1,3 1,45 -0,62 3,32 0 Rejected
SMO_cn -0,79 -0,58 -2,42 0,71 0 Rejected
SOCS1_cn 0,32 0,69 -1,28 1,53 0 Rejected
STK11_wt 1,09 0,88 -0,86 3,28 0 Rejected
STK11_cn -0,13 -0,29 -2,06 1,5 0 Rejected
TET2_wt 4,54 4,61 2,45 7,24 0,858585859 Confirmed
TP53_wt 11,9 11,88 9,42 14,36 1 Confirmed
TP53_cn 0,24 0,13 -2,15 2,2 0 Rejected
TSC1_wt 1,84 1,62 0,25 3,52 0 Rejected
TSC1_cn 2,15 2,25 -0,2 3,49 0,01010101 Rejected
VHL_wt 1,06 1,13 -0,23 2,23 0 Rejected
VHL_cn 1,27 1,37 -1,22 2,83 0 Rejected
WT1_cn 1,38 1,4 -0,46 2,52 0 Rejected
PubchemFP0 2,08 1,94 1,2 2,94 0 Rejected
PubchemFP1 1,8 1,87 1,06 2,29 0 Rejected
PubchemFP2 -0,23 -0,7 -1,45 1,26 0 Rejected
PubchemFP6 4,8 4,75 3,59 6,43 0,96969697 Confirmed
PubchemFP9 1,67 1,73 1 2,09 0 Rejected
PubchemFP10 1,65 1,61 1 2,65 0 Rejected
PubchemFP11 2,11 2,07 1,51 3,13 0 Rejected
PubchemFP12 2,16 2,13 1,7 2,68 0 Rejected
PubchemFP13 1,68 1,63 0,96 2,37 0 Rejected
PubchemFP14 2,23 2,17 1,34 2,9 0 Rejected
PubchemFP15 2,29 2,18 1,58 3,13 0 Rejected
PubchemFP16 3,75 3,72 2,62 5,04 0,727272727 Confirmed
PubchemFP17 1,57 1,5 0,77 2,39 0 Rejected
PubchemFP18 1,77 1,77 1,3 2,6 0 Rejected
PubchemFP19 3,83 3,87 1,73 5,41 0,787878788 Confirmed
PubchemFP20 4,82 4,85 3,17 5,93 0,949494949 Confirmed
PubchemFP21 2,92 2,96 1,89 3,81 0,292929293 Tentative
PubchemFP22 2,29 2,29 1,66 3,03 0 Rejected
PubchemFP23 3,32 3,26 1,87 5,68 0,464646465 Tentative
PubchemFP24 3,03 2,93 1,82 4,57 0,343434343 Tentative
PubchemFP25 2,06 1,95 1,1 3,18 0 Rejected
PubchemFP30 3,33 3,42 2,11 4,49 0,484848485 Tentative
PubchemFP33 2,98 3,02 2 3,79 0,03030303 Rejected
PubchemFP34 3,4 3,43 2,01 4,43 0,535353535 Tentative
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PubchemFP37 3,51 3,56 1,91 5,21 0,575757576 Tentative
PubchemFP38 3,12 3,2 2,39 3,77 0,01010101 Rejected
PubchemFP43 1,7 1,73 1,09 2,27 0 Rejected
PubchemFP44 1,63 1,52 1,11 2,74 0 Rejected
PubchemFP46 2,95 2,9 2,29 4,07 0,060606061 Rejected
PubchemFP93 1,9 1,92 1,27 2,32 0 Rejected
PubchemFP115 2,2 2,08 1,48 3,22 0 Rejected
PubchemFP116 2,41 2,5 1,65 3,11 0 Rejected
PubchemFP117 1,67 1,73 0,93 2,36 0 Rejected
PubchemFP118 1,89 2,08 0,91 2,52 0 Rejected
PubchemFP129 0,73 0,97 -1,12 1,54 0 Rejected
PubchemFP130 0,58 0,74 -1,49 1,82 0 Rejected
PubchemFP132 0,75 0,97 -0,46 1,79 0 Rejected
PubchemFP143 3,72 3,71 1,71 5,82 0,626262626 Tentative
PubchemFP144 2,57 2,56 1,95 3,37 0 Rejected
PubchemFP145 3,2 3,17 1,85 4,83 0,424242424 Tentative
PubchemFP146 3,81 3,79 2,2 5,82 0,666666667 Tentative
PubchemFP147 1,01 1,18 0,02 1,69 0 Rejected
PubchemFP148 3,21 3,18 2,18 4,78 0,393939394 Tentative
PubchemFP149 3,33 3,37 2,34 4,27 0,454545455 Tentative
PubchemFP150 3,39 3,35 2,11 5,53 0,505050505 Tentative
PubchemFP152 3,83 3,86 2,8 4,78 0,686868687 Confirmed
PubchemFP153 3,24 3,25 2,05 4,35 0,434343434 Tentative
PubchemFP155 3,85 3,87 2,83 5,1 0,717171717 Confirmed
PubchemFP156 3,9 3,95 2,6 4,95 0,757575758 Confirmed
PubchemFP157 4,05 4,04 2,95 5,08 0,818181818 Confirmed
PubchemFP159 2,46 2,47 1,64 3,83 0 Rejected
PubchemFP160 2,35 2,32 1,6 3,64 0 Rejected
PubchemFP164 1,58 1,63 1,01 2,22 0 Rejected
PubchemFP167 1,22 1,29 -0,19 1,79 0 Rejected
PubchemFP178 4,31 4,37 3 5,9 0,858585859 Confirmed
PubchemFP179 2,2 2,23 1,62 2,85 0 Rejected
PubchemFP180 3,56 3,58 2,28 4,58 0,616161616 Tentative
PubchemFP181 3,58 3,57 2,56 4,64 0,636363636 Tentative
PubchemFP182 3,5 3,54 2,05 4,5 0,616161616 Tentative
PubchemFP183 2,42 2,54 1,43 2,81 0 Rejected
PubchemFP184 2,41 2,35 1,77 3,11 0 Rejected
PubchemFP185 2,69 2,58 2,14 3,34 0 Rejected
PubchemFP186 3,8 3,78 2,56 4,8 0,737373737 Confirmed
PubchemFP187 4,41 4,42 3,36 5,61 0,939393939 Confirmed
PubchemFP188 4,72 4,65 3,5 6,15 0,95959596 Confirmed
PubchemFP189 1,66 1,65 1,05 2,55 0 Rejected
PubchemFP190 -1,08 -1,04 -2,39 0,34 0 Rejected
PubchemFP191 3,24 3,24 2,03 4,33 0,424242424 Tentative
PubchemFP192 3,46 3,51 1,63 4,75 0,505050505 Tentative
PubchemFP193 3,58 3,6 2,05 4,8 0,666666667 Tentative
PubchemFP194 2,9 2,86 2,07 4,06 0,03030303 Rejected
PubchemFP195 2,71 2,72 1,84 3,43 0,080808081 Rejected
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PubchemFP199 2,72 2,81 1,82 3,58 0 Rejected
PubchemFP200 2,25 2,18 1,7 3,03 0 Rejected
PubchemFP206 3,07 3,05 1,86 4,31 0,393939394 Tentative
PubchemFP213 1,85 1,83 1,18 2,63 0 Rejected
PubchemFP214 -0,39 -0,85 -1,84 1,52 0 Rejected
PubchemFP218 1,77 1,82 1,23 2,26 0 Rejected
PubchemFP219 1,75 1,72 1,05 2,29 0 Rejected
PubchemFP227 0,3 0,65 -1,62 1,66 0 Rejected
PubchemFP228 0,96 1 0,13 1,42 0 Rejected
PubchemFP232 -0,35 -0,47 -1,91 1,33 0 Rejected
PubchemFP233 -1,31 -1,64 -2,63 0,42 0 Rejected
PubchemFP241 1,31 1,39 -0,08 2,5 0 Rejected
PubchemFP246 1,36 1,32 -0,44 2,7 0 Rejected
PubchemFP247 1,25 1,29 -0,79 2,41 0 Rejected
PubchemFP248 0,66 0,99 -0,89 1,37 0 Rejected
PubchemFP252 0,96 1,14 -1,03 1,62 0 Rejected
PubchemFP255 2,3 2,27 1,83 3,26 0 Rejected
PubchemFP256 2,79 2,79 1,78 3,82 0,02020202 Rejected
PubchemFP257 3,13 3,08 2,11 4,37 0,373737374 Tentative
PubchemFP258 3,47 3,49 1,95 4,86 0,585858586 Tentative
PubchemFP259 3,15 3,13 1,98 4,21 0,373737374 Tentative
PubchemFP260 2,61 2,56 2,1 3,07 0 Rejected
PubchemFP261 3,6 3,61 2,62 4,6 0,616161616 Tentative
PubchemFP262 1,45 1,65 -0,07 2,53 0 Rejected
PubchemFP274 4,81 4,84 3,28 6,18 0,95959596 Confirmed
PubchemFP276 4,89 4,88 3,1 6,13 0,949494949 Confirmed
PubchemFP283 1,58 1,56 1,04 2,18 0 Rejected
PubchemFP284 1,82 1,78 1,06 2,92 0 Rejected
PubchemFP285 2,82 2,97 1,66 3,32 0 Rejected
PubchemFP286 1,93 1,8 1,22 2,71 0 Rejected
PubchemFP287 3,39 3,35 1,84 5,47 0,505050505 Tentative
PubchemFP293 3,08 3,1 1,74 4,39 0,373737374 Tentative
PubchemFP294 3,06 2,95 1,83 4,52 0,373737374 Tentative
PubchemFP297 1,45 1,35 1 2,06 0 Rejected
PubchemFP298 2,76 2,68 2,26 3,59 0 Rejected
PubchemFP299 2,8 2,92 1,86 3,37 0 Rejected
PubchemFP300 2,5 2,36 1,59 3,95 0,01010101 Rejected
PubchemFP301 4,19 4,2 3,07 5,45 0,858585859 Confirmed
PubchemFP305 1,84 1,85 0,38 2,96 0 Rejected
PubchemFP308 6,43 6,42 4,85 7,53 0,98989899 Confirmed
PubchemFP314 3,23 3,2 2,31 4,34 0,383838384 Tentative
PubchemFP327 1,73 1,64 1,11 2,42 0 Rejected
PubchemFP328 1,72 1,76 1,21 2,63 0 Rejected
PubchemFP330 1,68 1,61 1,28 2,24 0 Rejected
PubchemFP332 2,06 2,09 1,27 2,92 0 Rejected
PubchemFP333 2,33 2,28 1,86 3,4 0 Rejected
PubchemFP334 3,43 3,49 2,3 4,71 0,505050505 Tentative
PubchemFP335 3,63 3,6 2,32 4,62 0,656565657 Tentative
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PubchemFP336 2,68 2,71 1,31 3,4 0,02020202 Rejected
PubchemFP337 4,27 4,27 3,31 5,58 0,898989899 Confirmed
PubchemFP338 2,86 2,81 1,81 4,46 0,303030303 Tentative
PubchemFP339 3,27 3,26 2,5 4,38 0,414141414 Tentative
PubchemFP340 2,24 2,13 1,12 3,57 0 Rejected
PubchemFP341 2,68 2,57 1,88 4,24 0,01010101 Rejected
PubchemFP342 2,78 2,84 1,8 3,32 0 Rejected
PubchemFP344 1,71 1,71 1,07 2,46 0 Rejected
PubchemFP345 3,33 3,39 1,92 4,64 0,515151515 Tentative
PubchemFP346 3,63 3,65 2,72 5,24 0,646464646 Tentative
PubchemFP347 1,74 1,69 1,02 2,44 0 Rejected
PubchemFP349 3,02 3,03 1,58 4,46 0,292929293 Tentative
PubchemFP350 2,84 2,96 1,92 3,58 0 Rejected
PubchemFP351 2,19 2,18 1,15 3,26 0 Rejected
PubchemFP352 1,91 1,86 1,23 2,68 0 Rejected
PubchemFP353 3,06 3,04 1,94 4,21 0,343434343 Tentative
PubchemFP355 2,28 2,26 1,5 3,04 0 Rejected
PubchemFP356 2,71 2,79 1,79 4,03 0 Rejected
PubchemFP357 3,51 3,53 2,14 5,26 0,565656566 Tentative
PubchemFP358 2,62 2,61 2,02 3,39 0 Rejected
PubchemFP359 2,64 2,71 1,89 3,37 0,02020202 Rejected
PubchemFP360 -0,27 -0,42 -1,95 1,03 0 Rejected
PubchemFP362 2,89 2,89 2,17 3,74 0,050505051 Rejected
PubchemFP363 2,43 2,47 1,46 3,93 0,01010101 Rejected
PubchemFP364 2,85 2,89 1,86 4,3 0,02020202 Rejected
PubchemFP365 3,3 3,3 1,68 4,48 0,444444444 Tentative
PubchemFP366 4,18 4,24 3,19 5,08 0,868686869 Confirmed
PubchemFP367 1,9 1,91 1,27 2,69 0 Rejected
PubchemFP368 3,35 3,35 2,29 4,47 0,494949495 Tentative
PubchemFP370 2,2 2,14 1,37 3,08 0 Rejected
PubchemFP371 2,03 2,09 1,49 2,6 0 Rejected
PubchemFP372 3,42 3,43 1,88 5,06 0,525252525 Tentative
PubchemFP373 3,18 3,16 2,05 4,74 0,353535354 Tentative
PubchemFP374 3,28 3,28 1,92 4,71 0,454545455 Tentative
PubchemFP375 3,46 3,49 2,21 4,99 0,515151515 Tentative
PubchemFP376 3,18 3,27 2,03 4,16 0,383838384 Tentative
PubchemFP377 3,95 3,99 2,66 5,38 0,747474747 Confirmed
PubchemFP378 2,93 2,8 1,85 4,37 0,282828283 Rejected
PubchemFP379 2,51 2,65 1,87 3,24 0 Rejected
PubchemFP380 3,14 3,18 2,15 3,92 0,383838384 Tentative
PubchemFP381 2,9 2,85 2,43 3,93 0 Rejected
PubchemFP382 2,78 2,73 1,85 3,85 0,01010101 Rejected
PubchemFP383 3,08 3,07 2,01 4,18 0,343434343 Tentative
PubchemFP384 2,12 2,23 1,49 2,69 0 Rejected
PubchemFP385 3,32 3,31 1,93 5,05 0,515151515 Tentative
PubchemFP386 3,63 3,66 1,8 5,37 0,636363636 Tentative
PubchemFP387 2,99 2,99 1,81 4,01 0,313131313 Tentative
PubchemFP388 2,26 2,33 1,2 3,24 0 Rejected
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PubchemFP389 3,11 3,13 1,74 4,27 0,393939394 Tentative
PubchemFP390 2,76 2,77 1,78 3,57 0,080808081 Rejected
PubchemFP391 4,07 4,06 2,58 5,08 0,828282828 Confirmed
PubchemFP392 3,41 3,44 2,31 4,64 0,484848485 Tentative
PubchemFP393 3,44 3,43 1,86 4,76 0,545454545 Tentative
PubchemFP394 2,71 2,75 1,89 3,52 0,01010101 Rejected
PubchemFP395 3,97 3,98 2,89 5,07 0,797979798 Confirmed
PubchemFP396 2,82 2,85 1,9 3,89 0,03030303 Rejected
PubchemFP397 2,91 2,94 2,27 3,29 0 Rejected
PubchemFP398 2,66 2,68 1,48 3,7 0,04040404 Rejected
PubchemFP399 2,86 2,88 1,79 3,83 0,090909091 Rejected
PubchemFP400 2,83 2,83 1,82 3,48 0,02020202 Rejected
PubchemFP403 3,67 3,64 2,32 4,89 0,686868687 Tentative
PubchemFP404 1,52 1,55 0,55 2,26 0 Rejected
PubchemFP405 2,41 2,44 1,68 3,28 0 Rejected
PubchemFP406 4,55 4,51 3,64 5,78 0,95959596 Confirmed
PubchemFP407 3,21 3,26 2,1 4,29 0,424242424 Tentative
PubchemFP408 2,99 3 2,18 4,1 0,363636364 Tentative
PubchemFP409 0,46 0,4 -1,18 1,67 0 Rejected
PubchemFP411 3,3 3,33 2,06 4,2 0,434343434 Tentative
PubchemFP412 3,26 3,26 1,97 4,42 0,515151515 Tentative
PubchemFP413 1,62 1,72 0,98 2,03 0 Rejected
PubchemFP414 2,9 2,9 1,75 4,9 0,282828283 Rejected
PubchemFP416 2,32 2,25 1,43 3,13 0 Rejected
PubchemFP417 2,6 2,61 1,71 3,54 0 Rejected
PubchemFP418 3,7 3,73 2,45 5,18 0,676767677 Tentative
PubchemFP419 2,89 2,94 1,57 3,95 0,323232323 Tentative
PubchemFP420 2,58 2,42 1,69 3,56 0 Rejected
PubchemFP421 2,13 2,16 1,2 2,84 0 Rejected
PubchemFP422 3,13 3,14 1,9 3,98 0,373737374 Tentative
PubchemFP423 0,79 1,18 -1,14 1,68 0 Rejected
PubchemFP425 3,23 3,26 1,86 4,22 0,424242424 Tentative
PubchemFP427 2,26 2,14 1,55 3,06 0 Rejected
PubchemFP428 0,96 1,28 -1,72 1,8 0 Rejected
PubchemFP429 2,61 2,43 1,59 3,35 0 Rejected
PubchemFP430 3,22 3,29 2,24 4,29 0,454545455 Tentative
PubchemFP431 3,4 3,43 1,97 4,84 0,525252525 Tentative
PubchemFP432 3,57 3,59 2,13 4,81 0,585858586 Tentative
PubchemFP434 3,29 3,3 1,9 4,39 0,434343434 Tentative
PubchemFP435 3,57 3,54 2,43 5,25 0,626262626 Tentative
PubchemFP436 0,78 0,87 -1,41 1,66 0 Rejected
PubchemFP437 2,81 2,89 1,5 3,24 0 Rejected
PubchemFP438 3,23 3,22 1,45 4,62 0,484848485 Tentative
PubchemFP439 4,58 4,58 2,64 6 0,898989899 Confirmed
PubchemFP440 3,15 3,17 2,3 4,21 0,353535354 Tentative
PubchemFP441 2,3 2,26 1,65 3,09 0 Rejected
PubchemFP442 2,66 2,67 2,01 3,52 0 Rejected
PubchemFP443 2,87 2,9 1,95 4,01 0,080808081 Rejected
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PubchemFP445 3,15 3,15 1,68 4,73 0,373737374 Tentative
PubchemFP446 3,57 3,62 2,19 4,87 0,616161616 Tentative
PubchemFP447 3,46 3,47 2 4,65 0,545454545 Tentative
PubchemFP448 0,5 0,76 -1,28 1,64 0 Rejected
PubchemFP449 2,3 2,22 1,47 3,48 0 Rejected
PubchemFP450 3,25 3,24 1,92 5,1 0,444444444 Tentative
PubchemFP451 2,81 2,77 1,79 3,56 0 Rejected
PubchemFP452 2,93 3,06 2,18 3,56 0,02020202 Rejected
PubchemFP453 3,69 3,7 2,24 4,85 0,666666667 Tentative
PubchemFP454 0,93 1 -0,45 1,88 0 Rejected
PubchemFP456 2,96 2,99 2,21 3,64 0 Rejected
PubchemFP457 2,9 2,83 1,92 4,02 0,050505051 Rejected
PubchemFP458 2,93 2,93 2 4 0,101010101 Rejected
PubchemFP459 2,74 2,77 1,61 3,56 0,03030303 Rejected
PubchemFP460 2,29 2,22 1,69 3,23 0 Rejected
PubchemFP461 2,79 2,78 2,09 3,21 0 Rejected
PubchemFP462 3,42 3,48 2,17 4,35 0,555555556 Tentative
PubchemFP464 2,42 2,26 1,37 3,7 0 Rejected
PubchemFP465 3,42 3,42 2,24 4,54 0,494949495 Tentative
PubchemFP466 2,98 3,01 1,91 4,41 0,131313131 Rejected
PubchemFP467 2,9 2,84 1,29 4,7 0,313131313 Tentative
PubchemFP469 0,2 0,75 -1,96 1,64 0 Rejected
PubchemFP470 2,34 2,39 1,09 3,35 0 Rejected
PubchemFP471 2,79 2,9 1,57 3,91 0,060606061 Rejected
PubchemFP472 3,72 3,76 1,99 4,95 0,656565657 Tentative
PubchemFP473 1,1 1,21 -0,28 1,8 0 Rejected
PubchemFP474 0,92 1,07 -1,4 2,08 0 Rejected
PubchemFP475 0,77 1,11 -1,74 2,07 0 Rejected
PubchemFP476 2,64 2,52 1,3 3,64 0,02020202 Rejected
PubchemFP477 3,03 3,06 1,64 4,19 0,383838384 Tentative
PubchemFP480 2,2 2,29 1,02 2,98 0 Rejected
PubchemFP481 1,93 1,95 1,14 2,94 0 Rejected
PubchemFP482 2,63 2,71 1,89 3,33 0,01010101 Rejected
PubchemFP483 1,4 1,25 0,55 2,32 0 Rejected
PubchemFP484 2,82 2,79 1,68 4,12 0,202020202 Rejected
PubchemFP485 3,16 3,22 1,82 4,51 0,424242424 Tentative
PubchemFP486 2,58 2,58 1,8 3,58 0,03030303 Rejected
PubchemFP487 3,19 3,09 2,09 5,26 0,464646465 Tentative
PubchemFP489 1,58 1,62 0,1 2,47 0 Rejected
PubchemFP490 2,27 2,24 1,27 3,08 0 Rejected
PubchemFP493 3,93 3,99 1,86 5,74 0,686868687 Tentative
PubchemFP494 2,9 2,89 2,28 3,62 0,03030303 Rejected
PubchemFP495 2,81 2,82 2,14 3,4 0 Rejected
PubchemFP497 2,86 2,85 2 3,54 0 Rejected
PubchemFP498 3,67 3,71 2,16 5,15 0,676767677 Tentative
PubchemFP499 3,48 3,57 1,8 4,69 0,575757576 Tentative
PubchemFP500 3,05 3,06 1,93 4,24 0,343434343 Tentative
PubchemFP501 2,99 2,9 2,42 3,71 0 Rejected
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PubchemFP504 3,06 3,01 1,7 4,27 0,313131313 Tentative
PubchemFP505 1,19 1,32 -0,41 2,07 0 Rejected
PubchemFP506 3,6 3,62 2,22 5,06 0,595959596 Tentative
PubchemFP507 2,97 2,93 2,24 4,11 0 Rejected
PubchemFP508 1,32 1,43 0,12 2,35 0 Rejected
PubchemFP509 1,59 1,52 1 2,21 0 Rejected
PubchemFP514 5,17 5,21 3,58 6,36 0,95959596 Confirmed
PubchemFP515 2,69 2,5 1,96 3,66 0,01010101 Rejected
PubchemFP516 2,18 2,19 1,45 2,83 0 Rejected
PubchemFP517 2,45 2,55 1,17 3,27 0,01010101 Rejected
PubchemFP518 1,57 1,48 0,92 2,42 0 Rejected
PubchemFP519 3,59 3,56 2,18 4,83 0,686868687 Tentative
PubchemFP520 2,23 2,22 1,4 2,91 0 Rejected
PubchemFP521 2,95 2,9 2,19 3,94 0,090909091 Rejected
PubchemFP523 2,62 2,68 1,73 3,43 0 Rejected
PubchemFP524 2,42 2,4 1,64 2,95 0 Rejected
PubchemFP530 2,42 2,57 1,41 3,28 0 Rejected
PubchemFP531 3,22 3,27 1,94 4,41 0,484848485 Tentative
PubchemFP533 1,75 1,92 0,53 2,72 0 Rejected
PubchemFP534 2,44 2,47 1,26 3,07 0 Rejected
PubchemFP535 2,94 2,92 1,92 3,95 0,03030303 Rejected
PubchemFP536 4,06 3,99 2,98 5,21 0,828282828 Confirmed
PubchemFP537 3,45 3,42 2,38 4,5 0,535353535 Tentative
PubchemFP538 2,65 2,59 1,86 3,48 0 Rejected
PubchemFP539 -0,8 -1,06 -1,7 1,23 0 Rejected
PubchemFP540 3,32 3,32 2,25 4,58 0,494949495 Tentative
PubchemFP541 3,11 3,09 1,82 4,59 0,323232323 Tentative
PubchemFP543 2,76 2,61 2,04 3,42 0 Rejected
PubchemFP544 2,62 2,66 1,48 3,66 0,01010101 Rejected
PubchemFP545 2,93 2,9 2,15 3,95 0,03030303 Rejected
PubchemFP547 3,53 3,44 2,25 5,19 0,565656566 Tentative
PubchemFP548 3,13 3,14 1,91 4,74 0,414141414 Tentative
PubchemFP549 2,16 2,16 1,53 2,66 0 Rejected
PubchemFP550 3,05 3,03 2,04 4,27 0,333333333 Tentative
PubchemFP551 1,36 1,23 0,82 2,18 0 Rejected
PubchemFP552 2 1,93 1,17 2,88 0 Rejected
PubchemFP553 3,67 3,65 2,27 5,06 0,626262626 Tentative
PubchemFP554 1,53 1,45 1 2,34 0 Rejected
PubchemFP555 2,91 3,05 2,02 3,74 0,02020202 Rejected
PubchemFP556 2,5 2,42 1,92 3,42 0 Rejected
PubchemFP558 0,43 0,77 -1,18 1,8 0 Rejected
PubchemFP560 3,25 3,13 1,82 5,04 0,363636364 Tentative
PubchemFP563 2,57 2,6 1,91 3,24 0 Rejected
PubchemFP564 1,99 1,98 1,22 2,54 0 Rejected
PubchemFP565 2,42 2,47 1,76 3,16 0 Rejected
PubchemFP566 3,65 3,6 2,67 4,82 0,616161616 Tentative
PubchemFP567 3,21 3,18 2,09 4,13 0,414141414 Tentative
PubchemFP568 2,66 2,7 2,13 3,17 0 Rejected
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PubchemFP569 3,29 3,36 1,98 4,34 0,484848485 Tentative
PubchemFP570 2,03 2,01 1,11 2,48 0 Rejected
PubchemFP572 2,77 2,77 1,81 4,03 0,090909091 Rejected
PubchemFP573 2,99 3,07 2,17 3,78 0,01010101 Rejected
PubchemFP574 3,16 3,15 1,87 4,23 0,434343434 Tentative
PubchemFP575 2,25 2,22 1,42 3,17 0 Rejected
PubchemFP577 3,37 3,43 1,89 4,63 0,545454545 Tentative
PubchemFP578 2,05 2,05 1,55 2,62 0 Rejected
PubchemFP579 2,52 2,48 1,8 3,46 0 Rejected
PubchemFP580 2,75 2,66 1,68 3,75 0,02020202 Rejected
PubchemFP581 6,53 6,58 4,64 7,7 1 Confirmed
PubchemFP582 2,17 2,22 1,57 2,61 0 Rejected
PubchemFP583 1,37 1,59 -0,03 1,92 0 Rejected
PubchemFP584 2,11 2,06 1,62 2,95 0 Rejected
PubchemFP585 3,08 3,13 1,98 4,47 0,373737374 Tentative
PubchemFP586 3,35 3,36 2,28 4,48 0,444444444 Tentative
PubchemFP588 0,61 0,96 -1,33 1,39 0 Rejected
PubchemFP589 2,51 2,69 1,37 2,98 0 Rejected
PubchemFP591 3,01 2,98 1,71 4,44 0,363636364 Tentative
PubchemFP592 2,01 1,89 1,12 3,4 0,01010101 Rejected
PubchemFP593 3,75 3,76 1,53 5,01 0,686868687 Tentative
PubchemFP594 2,7 2,62 2,11 3,56 0,01010101 Rejected
PubchemFP595 2,13 2,12 1,3 2,85 0 Rejected
PubchemFP596 2,76 2,68 2,18 3,44 0,01010101 Rejected
PubchemFP597 3,33 3,21 1,52 5,4 0,373737374 Tentative
PubchemFP598 2,81 2,76 2,16 3,33 0 Rejected
PubchemFP599 2,16 2 1,46 3,1 0 Rejected
PubchemFP600 3,45 3,52 2,03 4,58 0,555555556 Tentative
PubchemFP601 3,32 3,34 1,97 4,49 0,525252525 Tentative
PubchemFP602 4 4,03 2,07 5,26 0,777777778 Confirmed
PubchemFP603 2,13 2,12 1,43 2,71 0 Rejected
PubchemFP604 2,91 2,9 1,66 4,38 0,303030303 Tentative
PubchemFP605 1,94 2,01 1,12 2,79 0 Rejected
PubchemFP606 2,88 2,93 2,15 3,58 0 Rejected
PubchemFP607 2,25 2,23 1,34 3,18 0 Rejected
PubchemFP608 2,17 2,16 1,33 2,74 0 Rejected
PubchemFP609 1,02 1,02 -0,26 2,23 0 Rejected
PubchemFP610 1,86 1,79 1,07 2,59 0 Rejected
PubchemFP611 3,26 3,27 2,07 4,1 0,474747475 Tentative
PubchemFP612 2,84 2,9 1,55 3,63 0,01010101 Rejected
PubchemFP613 1,96 1,93 1,21 2,7 0 Rejected
PubchemFP614 2,71 2,64 2,22 3,31 0 Rejected
PubchemFP615 3,58 3,55 2,63 4,52 0,616161616 Tentative
PubchemFP616 2,97 2,96 1,95 3,86 0,161616162 Rejected
PubchemFP618 2,05 2,05 1,65 2,67 0 Rejected
PubchemFP619 3,25 3,25 1,92 4,87 0,454545455 Tentative
PubchemFP620 2,93 2,89 2,2 3,98 0,101010101 Rejected
PubchemFP621 3,26 3,23 2,07 4,68 0,424242424 Tentative
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PubchemFP622 -1,45 -1,69 -2,39 0,62 0 Rejected
PubchemFP623 3,86 3,94 2,13 5,1 0,757575758 Confirmed
PubchemFP624 2,42 2,34 1,43 3,53 0 Rejected
PubchemFP625 2,64 2,65 1,8 3,26 0 Rejected
PubchemFP626 2,53 2,47 2,03 3,3 0 Rejected
PubchemFP628 2,26 2,31 1,69 2,91 0 Rejected
PubchemFP629 1,4 1,54 -0,35 2,4 0 Rejected
PubchemFP630 2,28 2,2 1,73 3,16 0 Rejected
PubchemFP632 2,82 2,78 1,66 3,73 0,01010101 Rejected
PubchemFP633 2,32 2,3 1,97 2,95 0 Rejected
PubchemFP634 2,05 1,97 1,47 2,6 0 Rejected
PubchemFP636 3,13 3,14 2,08 3,97 0,404040404 Tentative
PubchemFP637 3,06 3,12 1,37 4,46 0,414141414 Tentative
PubchemFP638 2,57 2,52 1,93 3,44 0 Rejected
PubchemFP639 3,2 3,17 1,97 4,12 0,404040404 Tentative
PubchemFP640 2,19 2,11 1,22 3,03 0 Rejected
PubchemFP641 3,42 3,4 2,07 4,67 0,545454545 Tentative
PubchemFP642 6,68 6,66 5,12 8,11 0,98989899 Confirmed
PubchemFP644 2,39 2,22 1,58 3,44 0,01010101 Rejected
PubchemFP645 3,08 2,9 1,49 5,24 0,292929293 Tentative
PubchemFP646 3,77 3,84 2,66 4,99 0,696969697 Confirmed
PubchemFP647 2,31 2,21 1,4 3,36 0 Rejected
PubchemFP648 0,07 0,61 -1,72 1,46 0 Rejected
PubchemFP650 2,11 2,08 1,55 2,78 0 Rejected
PubchemFP651 2,89 2,93 1,77 4,08 0,101010101 Rejected
PubchemFP652 2,57 2,63 1,94 3,16 0 Rejected
PubchemFP653 2,07 2,17 1,08 2,91 0 Rejected
PubchemFP654 2,59 2,55 1,89 3,22 0 Rejected
PubchemFP655 3,51 3,54 1,77 4,62 0,575757576 Tentative
PubchemFP656 2,17 2,11 1,34 3,36 0 Rejected
PubchemFP657 2,96 3 2,17 3,54 0,01010101 Rejected
PubchemFP658 3,2 3,25 1,64 4,3 0,444444444 Tentative
PubchemFP659 3,59 3,54 2,15 5,1 0,616161616 Tentative
PubchemFP660 2,39 2,38 1,48 3,2 0,02020202 Rejected
PubchemFP661 3,08 3,09 1,79 4,1 0,373737374 Tentative
PubchemFP662 2,75 2,7 1,71 3,99 0,101010101 Rejected
PubchemFP664 2,02 1,95 1,12 3,16 0 Rejected
PubchemFP665 3,4 3,43 2,31 4,66 0,505050505 Tentative
PubchemFP666 2,81 2,77 1,75 3,75 0,090909091 Rejected
PubchemFP668 1,93 1,93 1,33 2,46 0 Rejected
PubchemFP669 2,16 2,17 1,19 2,93 0 Rejected
PubchemFP670 1,61 1,61 1,11 2,76 0 Rejected
PubchemFP671 3,55 3,53 2,25 4,66 0,626262626 Tentative
PubchemFP673 3,29 3,28 2,24 4,77 0,404040404 Tentative
PubchemFP674 2,76 2,76 1,96 3,55 0 Rejected
PubchemFP675 1,23 1,3 -1,29 2,09 0 Rejected
PubchemFP676 2,61 2,73 1,88 3,32 0 Rejected
PubchemFP677 2,36 2,4 1,61 3,14 0 Rejected
52 Boruta Results
PubchemFP678 2,1 2,01 1,34 3,27 0 Rejected
PubchemFP679 1,84 1,74 1,23 2,4 0 Rejected
PubchemFP680 2,83 2,56 2,04 4,37 0 Rejected
PubchemFP681 3,07 3,05 1,91 4,33 0,333333333 Tentative
PubchemFP682 3,6 3,7 2,34 4,82 0,646464646 Tentative
PubchemFP683 2,02 2,06 1,29 3,29 0,01010101 Rejected
PubchemFP684 3,12 2,93 1,63 5 0,373737374 Tentative
PubchemFP685 3,16 3,18 1,75 4,41 0,434343434 Tentative
PubchemFP686 3,78 3,76 2,62 5,19 0,656565657 Tentative
PubchemFP687 3,87 3,88 2,55 5,21 0,767676768 Confirmed
PubchemFP688 4,94 4,97 3,69 6,18 0,96969697 Confirmed
PubchemFP689 2,48 2,44 1,56 3,77 0,01010101 Rejected
PubchemFP690 2,87 2,84 1,6 4,11 0,121212121 Rejected
PubchemFP691 3,4 3,42 1,88 4,85 0,515151515 Tentative
PubchemFP692 3,42 3,46 1,69 5,78 0,515151515 Tentative
PubchemFP693 2,47 2,38 1,72 3,69 0 Rejected
PubchemFP694 2,13 2,06 1,36 3,46 0 Rejected
PubchemFP695 3,66 3,65 2,55 5,42 0,676767677 Tentative
PubchemFP696 3,67 3,68 2,5 4,82 0,676767677 Tentative
PubchemFP697 3,23 3,17 1,56 5,58 0,414141414 Tentative
PubchemFP698 4,04 4,08 2,53 5,45 0,787878788 Confirmed
PubchemFP699 2,69 2,69 1,57 3,74 0 Rejected
PubchemFP700 2,15 2,24 1,49 2,62 0 Rejected
PubchemFP701 2,57 2,45 1,43 3,67 0,04040404 Rejected
PubchemFP702 3,27 3,24 2,03 4,93 0,434343434 Tentative
PubchemFP703 3,46 3,45 2,03 4,85 0,525252525 Tentative
PubchemFP704 3,19 2,98 1,54 5,51 0,414141414 Tentative
PubchemFP705 2,47 2,47 1,61 3,33 0 Rejected
PubchemFP706 2,24 2,12 1,53 3 0 Rejected
PubchemFP707 3,27 3,27 2,12 4,54 0,454545455 Tentative
PubchemFP708 2,34 2,31 1,6 2,98 0 Rejected
PubchemFP709 2,89 2,95 1,78 4,3 0,090909091 Rejected
PubchemFP710 3,22 3,2 1,93 4,52 0,424242424 Tentative
PubchemFP711 3,45 3,43 2,35 4,6 0,545454545 Tentative
PubchemFP712 2,97 3,02 2,26 3,73 0 Rejected
PubchemFP713 3,76 3,76 2,74 5,36 0,676767677 Tentative
PubchemFP714 3,19 3,21 1,87 5,06 0,424242424 Tentative
PubchemFP715 2,46 2,56 1,74 3,37 0 Rejected
PubchemFP716 4,2 4,18 2,96 5,47 0,868686869 Confirmed
PubchemFP717 2,07 2,1 1,34 2,98 0 Rejected
PubchemFP719 2,85 2,81 1,98 3,88 0,101010101 Rejected
PubchemFP721 2,96 2,94 1,52 4,54 0,292929293 Tentative
PubchemFP722 1,53 1,55 0,79 2,28 0 Rejected
PubchemFP725 1,55 1,59 0,87 2,17 0 Rejected
PubchemFP728 1,96 1,97 1,31 2,67 0 Rejected
PubchemFP729 2,28 2,06 1,68 3,04 0 Rejected
PubchemFP733 1,53 1,48 1 2,04 0 Rejected
PubchemFP734 4 3,95 2,99 5,24 0,808080808 Confirmed
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PubchemFP735 3,67 3,57 2,11 5,16 0,626262626 Tentative
PubchemFP736 3,41 3,46 2,13 4,82 0,525252525 Tentative
PubchemFP737 3,15 3,09 2,26 4,3 0,131313131 Rejected
PubchemFP738 0,58 0,49 -0,59 2,12 0 Rejected
PubchemFP740 1,88 1,92 0,87 2,69 0 Rejected
PubchemFP742 3,15 3,21 1,77 4,11 0,404040404 Tentative
PubchemFP743 0,52 0,87 -0,99 1,69 0 Rejected
PubchemFP745 1,33 1,33 0,17 2,05 0 Rejected
PubchemFP746 1,57 1,73 0,38 2,28 0 Rejected
PubchemFP747 1,94 1,96 0,06 2,72 0 Rejected
PubchemFP749 2,94 3,02 1,88 3,77 0,090909091 Rejected
PubchemFP750 3,71 3,74 2,5 5,16 0,686868687 Tentative
PubchemFP751 1,63 1,64 1,03 2,36 0 Rejected
PubchemFP752 2,33 2,25 1,3 3,37 0 Rejected
PubchemFP755 3,51 3,51 2,22 5,14 0,585858586 Tentative
PubchemFP756 3,35 3,26 2,38 4,53 0,444444444 Tentative
PubchemFP757 2,17 2,11 1,67 3,33 0 Rejected
PubchemFP758 3,74 3,71 2,17 4,88 0,666666667 Tentative
PubchemFP759 2,97 2,93 1,48 4,16 0,313131313 Tentative
PubchemFP761 2,82 2,79 1,89 3,82 0,050505051 Rejected
PubchemFP762 0,06 0,41 -2,25 1,78 0 Rejected
PubchemFP763 1,35 1,54 -0,07 2,11 0 Rejected
PubchemFP764 1,15 1,17 0,52 1,93 0 Rejected
PubchemFP766 1,52 1,51 1 2,23 0 Rejected
PubchemFP767 1,77 1,81 0,12 2,35 0 Rejected
PubchemFP770 2,75 2,79 1,96 3,42 0,01010101 Rejected
PubchemFP771 0,82 1,11 -1,17 2,15 0 Rejected
PubchemFP772 1,64 1,58 1,4 2,01 0 Rejected
PubchemFP776 3,81 3,83 2,66 5,14 0,727272727 Confirmed
PubchemFP777 3,05 3,04 1,65 4,2 0,333333333 Tentative
PubchemFP778 2,49 2,6 1,78 3,1 0 Rejected
PubchemFP779 4,12 4,17 2,04 5,35 0,828282828 Confirmed
PubchemFP780 2,2 2,11 1,54 3,25 0 Rejected
PubchemFP782 2,58 2,64 1,95 3,21 0 Rejected
PubchemFP784 3,07 3,07 1,68 4,85 0,343434343 Tentative
PubchemFP785 0,95 1,08 -1,54 2,01 0 Rejected
PubchemFP788 1,57 1,64 0,87 2,11 0 Rejected
PubchemFP791 2,19 2,27 1,23 2,91 0 Rejected
PubchemFP792 1,5 1,37 0,73 2,34 0 Rejected
PubchemFP796 1,51 1,46 1,1 2,32 0 Rejected
PubchemFP797 3,82 3,78 2,08 5,13 0,757575758 Confirmed
PubchemFP798 2,59 2,68 1,38 4,17 0 Rejected
PubchemFP799 3,38 3,36 2,35 4,52 0,494949495 Tentative
PubchemFP800 3,38 3,35 2,56 4,49 0,515151515 Tentative
PubchemFP801 0,28 0,23 -1,01 1,84 0 Rejected
PubchemFP803 1,75 1,58 1,16 2,81 0 Rejected
PubchemFP805 2,94 2,96 1,63 4,03 0,131313131 Rejected
PubchemFP806 1,05 1,12 -0,14 1,75 0 Rejected
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PubchemFP808 0,74 1,18 -1,73 1,75 0 Rejected
PubchemFP809 1,79 1,88 1,04 2,49 0 Rejected
PubchemFP810 2,16 2,1 1,67 2,77 0 Rejected
PubchemFP812 3,16 3,16 1,83 4,23 0,383838384 Tentative
PubchemFP813 3,72 3,73 2,43 5,25 0,686868687 Tentative
PubchemFP814 1,4 1,35 1,08 1,79 0 Rejected
PubchemFP815 2,18 2,21 1,53 3,11 0 Rejected
PubchemFP818 3,34 3,35 1,93 4,72 0,535353535 Tentative
PubchemFP819 3,43 3,44 2,35 4,71 0,565656566 Tentative
PubchemFP820 1,96 1,98 1,33 2,42 0 Rejected
PubchemFP821 3,85 3,86 2,03 5,25 0,717171717 Confirmed
PubchemFP822 3,08 3 1,64 4,4 0,373737374 Tentative
PubchemFP824 1,95 1,89 1,28 3,25 0 Rejected
PubchemFP825 0,15 0,46 -1,73 1,26 0 Rejected
PubchemFP826 2,06 1,96 0,76 2,97 0 Rejected
PubchemFP827 1,05 1,02 0,07 2,06 0 Rejected
PubchemFP829 1,61 1,52 1,12 2,76 0 Rejected
PubchemFP830 1,85 2,02 0,25 2,62 0 Rejected
PubchemFP833 2,73 2,81 2,12 3,57 0 Rejected
PubchemFP834 0,92 0,86 -1,32 2,3 0 Rejected
PubchemFP835 1,41 1,36 1,05 1,95 0 Rejected
PubchemFP839 1,77 1,68 1,25 2,7 0 Rejected
PubchemFP840 0,54 0,87 -2,45 1,51 0 Rejected
PubchemFP860 1,58 1,39 0,97 2,4 0 Rejected
PubchemFP861 -0,03 0,25 -1,71 1,12 0 Rejected
nAcid 2,98 2,91 2,33 3,63 0,060606061 Rejected
apol 6,77 6,78 5,32 8,11 1 Confirmed
naAromAtom 6,51 6,48 5,39 7,97 1 Confirmed
nAromBond 6,37 6,47 4,53 7,61 0,98989899 Confirmed
nAtom 6,79 6,82 5,89 7,89 1 Confirmed
nHeavyAtom 5,99 6,01 4,94 7,22 0,98989899 Confirmed
nH 7,17 7,2 6,01 8,55 1 Confirmed
nB 4,81 4,81 3,66 5,96 0,949494949 Confirmed
nC 7,01 6,94 5,52 8,66 0,98989899 Confirmed
nN 5,31 5,29 3,85 6,71 0,96969697 Confirmed
nO 6,94 6,95 5,8 7,9 1 Confirmed
nS 4,16 4,26 2,31 5,81 0,777777778 Confirmed
nP 3,33 3,31 1,56 4,85 0,494949495 Tentative
nF 3,87 3,91 2,2 5,47 0,676767677 Tentative
nCl 4,01 3,97 2,3 5,45 0,777777778 Confirmed
nBr 1,64 1,57 1,23 2,2 0 Rejected
nI 2,76 2,78 2,18 3,38 0 Rejected
ATSc1 7,22 7,23 5,94 8,44 1 Confirmed
ATSc2 7,24 7,28 6,26 8,2 1 Confirmed
ATSc3 9,88 9,89 8,27 11,48 1 Confirmed
ATSc4 8,78 8,81 7,3 10,69 1 Confirmed
ATSc5 9,23 9,15 7,78 10,93 1 Confirmed
ATSm1 7,86 7,89 6,09 9,66 1 Confirmed
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ATSm2 6,47 6,47 5,08 8 0,98989899 Confirmed
ATSm3 6,35 6,38 5,24 7,73 0,98989899 Confirmed
ATSm4 6,91 6,91 5,68 8,09 0,98989899 Confirmed
ATSm5 6,63 6,68 5,27 8,04 1 Confirmed
ATSp1 6,74 6,8 4,9 8,3 1 Confirmed
ATSp2 6,73 6,76 5,32 7,93 1 Confirmed
ATSp3 6,66 6,66 5,4 8,15 0,98989899 Confirmed
ATSp4 7,17 7,2 6,23 8,27 1 Confirmed
ATSp5 6,76 6,75 5,56 7,79 1 Confirmed
nBase 5,94 5,92 4,42 7,22 0,98989899 Confirmed
nBonds 6,4 6,38 5,29 7,46 1 Confirmed
nBonds2 6,19 6,21 4,56 7,55 1 Confirmed
nBondsS 6,4 6,39 5,08 7,57 1 Confirmed
nBondsS2 7,44 7,43 6,01 8,59 1 Confirmed
nBondsS3 7,28 7,24 6,29 8,36 1 Confirmed
nBondsD 6,44 6,46 4,33 7,97 0,98989899 Confirmed
nBondsD2 6,05 6,02 4,61 8,06 0,98989899 Confirmed
nBondsT 2,79 2,71 2,06 3,89 0,01010101 Rejected
bpol 6,57 6,53 5,48 7,96 0,98989899 Confirmed
C1SP1 2,73 2,89 1,6 3,47 0 Rejected
C2SP1 2,44 2,55 1,7 3,32 0 Rejected
C1SP2 5,76 5,8 3,77 7,05 1 Confirmed
C2SP2 6,95 6,89 5,13 8,45 0,98989899 Confirmed
C3SP2 7,07 7,05 5,41 8,67 1 Confirmed
C1SP3 5,21 5,05 3,79 7,86 0,97979798 Confirmed
C2SP3 6,12 6,08 5,06 7,3 0,98989899 Confirmed
C3SP3 4,13 4,11 3,1 5,1 0,878787879 Confirmed
C4SP3 3,43 3,51 2,08 4,86 0,525252525 Tentative
SCH.3 2,29 2,18 1,35 4,15 0,01010101 Rejected
SCH.4 3,24 3,25 2,32 4,57 0,454545455 Tentative
SCH.5 5,58 5,63 3,99 6,9 0,96969697 Confirmed
SCH.6 8,02 7,97 6,68 9,72 1 Confirmed
SCH.7 7,27 7,2 5,66 8,66 1 Confirmed
VCH.3 2,44 2,48 1,65 3,47 0 Rejected
VCH.4 2,32 2,31 1,58 3,06 0 Rejected
VCH.5 6,35 6,34 4,5 7,77 1 Confirmed
VCH.6 7,16 7,13 5,17 9,28 1 Confirmed
VCH.7 7,48 7,47 5,69 8,85 1 Confirmed
SC.3 5,84 5,82 4,61 7,21 0,98989899 Confirmed
SC.4 6,18 6,2 4,94 7,3 1 Confirmed
SC.5 6,2 6,23 5,06 7,17 0,98989899 Confirmed
SC.6 4,9 4,87 2,94 6,45 0,939393939 Confirmed
VC.3 5,55 5,49 4,49 7,17 0,98989899 Confirmed
VC.4 6,46 6,46 4,82 8,09 0,98989899 Confirmed
VC.5 6,97 7,05 5,49 8,34 1 Confirmed
VC.6 6,01 5,93 4,63 7,3 0,98989899 Confirmed
SPC.4 5,89 5,93 4,92 6,7 0,98989899 Confirmed
SPC.5 7,41 7,42 6,16 8,83 1 Confirmed
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SPC.6 7,03 7,05 6,09 8,08 1 Confirmed
VPC.4 6,46 6,45 5,31 7,58 0,98989899 Confirmed
VPC.5 6,54 6,58 5,02 7,66 0,98989899 Confirmed
VPC.6 6,98 6,94 5,65 8,33 1 Confirmed
ECCEN 6,75 6,78 5,01 8,26 1 Confirmed
fragC 6,76 6,73 5,72 8,03 1 Confirmed
nHBAcc 5,92 5,95 4,91 7,08 1 Confirmed
nHBAcc2 6,15 6,18 4,97 7,22 0,98989899 Confirmed
nHBAcc3 6,5 6,51 4,96 7,82 1 Confirmed
nHBAcc_Lipinski 5,19 5,21 4,11 6,32 0,97979798 Confirmed
nHBDon 8,83 8,95 7,33 10,52 1 Confirmed
nHBDon_Lipinski 7,44 7,5 5,61 8,44 1 Confirmed
nAtomLC 7,39 7,46 6 8,99 1 Confirmed
nAtomP 6,11 6,08 4,99 7,47 0,98989899 Confirmed
nAtomLAC 5,68 5,68 4,12 6,88 0,98989899 Confirmed
MLogP 8,24 8,3 5,83 9,13 1 Confirmed
McGowan_Volume 7,04 7,08 5,57 8,34 1 Confirmed
MDEC.11 6 5,99 4,82 7,33 0,98989899 Confirmed
MDEC.12 6,49 6,52 5,26 7,63 1 Confirmed
MDEC.13 6,3 6,27 5,37 7,46 0,98989899 Confirmed
MDEC.14 5,84 5,83 3,84 7,21 0,98989899 Confirmed
MDEC.22 7,99 8,04 6,55 9,17 1 Confirmed
MDEC.23 6,92 6,99 5,79 7,85 1 Confirmed
MDEC.24 5,24 5,22 3,71 6,44 0,97979798 Confirmed
MDEC.33 6,92 6,94 6,05 7,81 1 Confirmed
MDEC.34 7,45 7,5 5,4 8,83 1 Confirmed
MDEC.44 4,13 4,09 3,21 5,38 0,838383838 Confirmed
MDEO.11 7,62 7,63 6,29 8,82 1 Confirmed
MDEO.12 9,74 9,88 7,4 11,51 1 Confirmed
MDEO.22 4,03 4,08 3,09 5,19 0,818181818 Confirmed
MDEN.11 4,95 4,98 3,45 5,9 0,97979798 Confirmed
MDEN.12 4,27 4,2 2,89 5,85 0,848484848 Confirmed
MDEN.13 6,41 6,49 5,04 7,45 0,98989899 Confirmed
MDEN.22 6,04 6,16 4,33 7,31 0,98989899 Confirmed
MDEN.23 5,21 5,14 3,88 7,25 0,97979798 Confirmed
MDEN.33 4,12 4,13 2,94 5,04 0,828282828 Confirmed
MLFER_A 8,01 8,06 6,73 9,55 1 Confirmed
MLFER_BH 7,29 7,34 5,64 8,64 1 Confirmed
MLFER_BO 7,75 7,76 6,38 8,84 1 Confirmed
MLFER_S 6,97 6,99 5,35 8,99 1 Confirmed
MLFER_E 6,83 6,88 5,55 7,88 1 Confirmed
MLFER_L 8,08 8,21 6 9,28 1 Confirmed
PetitjeanNumber 6,83 6,79 5,33 8,03 1 Confirmed
nRing 4,91 4,93 3,57 6,25 0,97979798 Confirmed
n3Ring 2,17 1,93 1,39 3,16 0 Rejected
n4Ring 1,03 1,19 -1,77 2,08 0 Rejected
n5Ring 5,55 5,57 4,18 6,58 0,98989899 Confirmed
n6Ring 5,59 5,59 4,4 6,73 0,98989899 Confirmed
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n7Ring 1,77 1,79 0,95 2,63 0 Rejected
n8Ring 1,05 1,35 -2,02 1,71 0 Rejected
n9Ring 1,38 1,29 0,36 2,11 0 Rejected
n10Ring 0,61 0,99 -1,42 1,88 0 Rejected
nG12Ring 2,64 2,63 1,98 3,19 0 Rejected
nFRing 5,36 5,34 4,11 6,46 0,97979798 Confirmed
nF6Ring 1,62 1,66 -0,2 2,22 0 Rejected
nF8Ring 1,91 1,87 1,41 2,42 0 Rejected
nF9Ring 4,1 4 2,72 6,21 0,747474747 Confirmed
nF10Ring 4,66 4,67 3,19 6,06 0,919191919 Confirmed
nF11Ring 1,79 1,78 1,25 2,47 0 Rejected
nF12Ring 2,76 2,9 1,46 3,32 0 Rejected
nFG12Ring 5,35 5,3 4,34 6,38 0,98989899 Confirmed
nTRing 6,31 6,33 5,13 7,4 0,98989899 Confirmed
nT4Ring 0,7 0,99 -1,32 1,69 0 Rejected
nT5Ring 5,38 5,33 3,76 6,56 0,98989899 Confirmed
nT6Ring 5,55 5,62 4,27 6,43 0,98989899 Confirmed
nT7Ring 1,73 1,76 0,85 2,26 0 Rejected
nT8Ring 2,04 2,11 1,19 3,04 0 Rejected
nT9Ring 4,22 4,17 2,96 6,74 0,828282828 Confirmed
nT10Ring 4,7 4,66 3,16 6,35 0,949494949 Confirmed
nT11Ring 1,93 1,91 1,26 2,9 0 Rejected
nT12Ring 2,68 2,66 1,74 4,24 0,03030303 Rejected
nTG12Ring 5,58 5,59 4,58 6,58 0,98989899 Confirmed
nRotB 6,21 6,22 4,66 7,58 0,98989899 Confirmed
TopoPSA 6,56 6,48 5,03 8,32 0,98989899 Confirmed
VAdjMat 5,98 6,01 4,68 7,26 1 Confirmed
MW 7,73 7,71 6,14 9,8 1 Confirmed
WTPT.1 6,93 6,97 5,24 8,14 1 Confirmed
WTPT.2 6,84 6,86 5,88 7,83 0,98989899 Confirmed
WTPT.3 6,3 6,28 5,19 7,53 0,98989899 Confirmed
WTPT.4 8,28 8,28 6,49 9,44 1 Confirmed
WTPT.5 6,83 6,76 5,68 8,13 1 Confirmed
WPATH 7,95 7,9 6,37 9,8 1 Confirmed
WPOL 6,63 6,65 5,42 8,03 0,98989899 Confirmed
Zagreb 6,42 6,39 4,73 7,74 0,98989899 Confirmed
Table C.1: Full Boruta results with importance and reject decision
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Appendix D
Feature Importance for gSpan folds
Feature IncMSE Feature IncMSE Feature IncMSE
MS.HL 56,33551731 AKT2_cn 16,05456617 ALK_wt -1,855406336
APC_wt 60,56943559 APC_cn 9,512828573 BRAF_wt 121,8226432
BRAF_cn -0,958455628 BRCA1_wt 22,68746517 BRCA2_wt 8,978954513
BRCA2_cn -0,339519667 CCND1_cn 29,05060436 CCND2_cn 29,49272811
CCND3_cn 0,267537424 CDH1_wt -16,14957804 CDH1_cn 10,8080078
CDK4_cn 19,21333122 CDK6_cn -3,404042328 CDKN2A_wt 122,007447
CDKN2A_cn 134,2255769 CDKN2C_wt 1,373084885 CDKN2C_cn 12,36115768
CDKN2a.p14._wt 153,7457211 CTNNB1_wt 25,17669328 CTNNB1_cn 14,0477282
CYLD_wt 4,067468675 EGFR_wt 7,44652644 EGFR_cn 0,889132715
EP300_cn 14,18503337 ERBB2_wt 7,108732684 ERBB2_cn 55,78107205
EZH2_wt -12,3794173 EZH2_cn -1,970967279 FAM123B_wt 10,5668683
FAM123B_cn 12,25838892 FBXW7_wt 30,18933049 FBXW7_cn 6,295771371
FGFR2_cn 30,10501665 FGFR3_wt 9,098347722 FGFR3_cn 9,414153789
FLCN_wt 5,47104567 FLT3_wt 4,051218248 FLT3_cn -0,848579219
GNAS_wt 16,27211687 GNAS_cn 17,4989612 HRAS_wt -39,21435245
IDH1_wt 12,32566845 IDH1_cn 8,616086164 JAK2_wt 9,264806901
JAK2_cn -0,242646969 KDM5C_wt 6,926119405 KDM5C_cn 2,686800292
KDM6A_wt 16,58677504 KDM6A_cn 4,005536184 KDR_cn 7,751043029
KIT_cn 13,33010909 KRAS_wt 111,5493929 KRAS_cn -1,450278417
MAP2K4_wt 14,49869672 MAP2K4_cn 3,158561346 MDM2_cn 29,3888009
MET_cn 18,37416265 MLH1_wt 61,49071831 MLH1_cn 3,453643234
MLLT3_cn -26,64515808 MSH2_wt -2,030550553 MSH2_cn 4,049141974
MSH6_wt -0,430785072 MSH6_cn 4,448594341 MYC_cn 40,05777068
MYCL1_cn 3,246714122 MYCN_cn 33,67147491 NF1_wt 29,65187136
NF1_cn 4,887243319 NF2_wt 40,1714892 NF2_cn 19,47629403
NOTCH1_wt 48,05918449 NRAS_wt 60,86243961 NRAS_cn 19,17492398
PDGFRA_cn -15,84609699 PIK3CA_wt 46,09398915 PIK3CA_cn 22,99938931
PIK3R1_wt 30,78934492 PIK3R1_cn 15,10361112 PTEN_wt 66,63034621
PTEN_cn 55,42201737 RB1_wt 33,50767448 RB1_cn 5,313157474
RUNX1_wt 9,562460173 SETD2_wt -13,7016384 SMAD4_wt 125,2284457
SMAD4_cn 1,90511325 SMARCA4_wt 11,93739617 SMARCA4_cn -3,844929231
SMARCB1_cn 1,322720248 SMO_cn -5,067195894 SOCS1_cn 0,979144347
STK11_wt 41,09522305 STK11_cn -2,391314291 TET2_wt 39,48124438
TP53_wt 66,76338137 TP53_cn -1,242357163 TSC1_wt 25,11899834
TSC1_cn 19,69118403 VHL_wt 18,33238528 VHL_cn 14,12852076
WT1_cn 7,969079223 PubchemFP0 5,035468619 PubchemFP1 0,752521081
PubchemFP2 -0,727583648 PubchemFP6 9,778226521 PubchemFP9 1,50941988
PubchemFP10 1,572153323 PubchemFP11 1,64273151 PubchemFP12 2,038613269
PubchemFP13 0,52464496 PubchemFP14 2,089585921 PubchemFP15 4,119376236
PubchemFP16 3,416851802 PubchemFP17 2,251364586 PubchemFP18 2,651439991
PubchemFP19 6,334751122 PubchemFP20 7,526925112 PubchemFP21 1,405399459
PubchemFP22 4,249062984 PubchemFP23 6,340606195 PubchemFP24 4,347539016
PubchemFP25 2,627703716 PubchemFP30 1,5750988 PubchemFP33 3,588704046
PubchemFP34 4,340509007 PubchemFP37 4,735557781 PubchemFP38 4,393460716
PubchemFP43 2,092036219 PubchemFP44 1,670459932 PubchemFP46 3,490975079
PubchemFP93 4,167294084 PubchemFP115 1,898937231 PubchemFP116 2,125094311
PubchemFP117 0,23584835 PubchemFP118 0,770053538 PubchemFP129 0,673594341
PubchemFP130 0,681782642 PubchemFP132 0,112819959 PubchemFP143 4,447260711
PubchemFP144 1,977295207 PubchemFP145 4,988148136 PubchemFP146 4,298797526
PubchemFP147 -2,492472564 PubchemFP148 3,421945192 PubchemFP149 3,346100388
PubchemFP150 3,953383976 PubchemFP152 3,961091716 PubchemFP153 2,943305466
PubchemFP155 5,762142508 PubchemFP156 5,790322808 PubchemFP157 6,137785825
PubchemFP159 1,658986287 PubchemFP160 1,765575423 PubchemFP164 1,090568457
PubchemFP167 0,692580181 PubchemFP178 13,09839813 PubchemFP179 1,830746696
PubchemFP180 5,543624655 PubchemFP181 3,841755281 PubchemFP182 3,607603577
PubchemFP183 2,182317658 PubchemFP184 2,62037662 PubchemFP185 1,505261329
PubchemFP186 2,912598029 PubchemFP187 15,92119099 PubchemFP188 10,58199805
PubchemFP189 0,854985581 PubchemFP190 -3,304221549 PubchemFP191 2,359198788
PubchemFP192 4,007219184 PubchemFP193 5,363962259 PubchemFP194 5,856501046
PubchemFP195 2,928128932 PubchemFP199 2,932757531 PubchemFP200 2,112327747
PubchemFP206 5,798364759 PubchemFP213 -2,070713526 PubchemFP214 -3,392875085
PubchemFP218 1,375421627 PubchemFP219 1,437694656 PubchemFP227 -2,205312332
PubchemFP228 0,327070955 PubchemFP232 -2,337298567 PubchemFP233 -3,039825938
PubchemFP241 0,580965068 PubchemFP246 0,587985031 PubchemFP247 0,557462073
PubchemFP248 1,138195392 PubchemFP252 0,281979609 PubchemFP255 2,183031488
PubchemFP256 3,200082677 PubchemFP257 3,239240945 PubchemFP258 3,581859076
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PubchemFP259 3,645707494 PubchemFP260 5,383852081 PubchemFP261 3,396994653
PubchemFP262 0,260697604 PubchemFP274 9,489842924 PubchemFP276 9,73303866
PubchemFP283 1,699943936 PubchemFP284 2,226823221 PubchemFP285 2,754361495
PubchemFP286 3,142872114 PubchemFP287 6,042216824 PubchemFP293 3,40661217
PubchemFP294 4,424720337 PubchemFP297 2,163793107 PubchemFP298 3,52476922
PubchemFP299 4,247559907 PubchemFP300 3,57026757 PubchemFP301 9,882203823
PubchemFP305 1,755239884 PubchemFP308 7,59258311 PubchemFP314 1,807685891
PubchemFP327 1,789212726 PubchemFP328 2,029866309 PubchemFP330 1,99003397
PubchemFP332 1,347041709 PubchemFP333 2,245755768 PubchemFP334 5,280809379
PubchemFP335 3,262431726 PubchemFP336 3,417376971 PubchemFP337 21,26925714
PubchemFP338 3,212313392 PubchemFP339 3,706597791 PubchemFP340 3,050818127
PubchemFP341 5,050882829 PubchemFP342 4,500048821 PubchemFP344 2,114378594
PubchemFP345 4,429391664 PubchemFP346 7,275694547 PubchemFP347 3,064296016
PubchemFP349 6,596801925 PubchemFP350 3,79495162 PubchemFP351 3,107698639
PubchemFP352 3,161583937 PubchemFP353 3,428715698 PubchemFP355 2,22820657
PubchemFP356 2,707268388 PubchemFP357 3,528529106 PubchemFP358 3,240715875
PubchemFP359 3,189534043 PubchemFP360 -0,073460272 PubchemFP362 4,759589312
PubchemFP363 6,345789851 PubchemFP364 5,404394126 PubchemFP365 3,301888238
PubchemFP366 4,403417199 PubchemFP367 2,811453697 PubchemFP368 3,687785375
PubchemFP370 1,62694668 PubchemFP371 0,896152142 PubchemFP372 4,100322872
PubchemFP373 2,544290732 PubchemFP374 6,524251158 PubchemFP375 5,388125927
PubchemFP376 2,253476728 PubchemFP377 3,998904935 PubchemFP378 3,012664359
PubchemFP379 1,739538989 PubchemFP380 2,088844879 PubchemFP381 2,395865041
PubchemFP382 2,92243145 PubchemFP383 1,784338744 PubchemFP384 1,981711201
PubchemFP385 3,321384179 PubchemFP386 4,608848331 PubchemFP387 3,124193313
PubchemFP388 2,24370451 PubchemFP389 2,150843379 PubchemFP390 2,177511627
PubchemFP391 4,359004486 PubchemFP392 2,871800257 PubchemFP393 4,35114589
PubchemFP394 3,040897483 PubchemFP395 9,441341356 PubchemFP396 3,241731305
PubchemFP397 2,658294356 PubchemFP398 2,72160104 PubchemFP399 1,945200372
PubchemFP400 1,750086581 PubchemFP403 2,264048303 PubchemFP404 0,018549222
PubchemFP405 3,514824917 PubchemFP406 3,795958968 PubchemFP407 1,640161
PubchemFP408 5,154791068 PubchemFP409 0,412641653 PubchemFP411 1,507783558
PubchemFP412 2,748535201 PubchemFP413 2,20760982 PubchemFP414 2,884584666
PubchemFP416 1,674767359 PubchemFP417 1,811059695 PubchemFP418 3,677145081
PubchemFP419 3,126702642 PubchemFP420 3,100899807 PubchemFP421 3,423907832
PubchemFP422 3,203204277 PubchemFP423 1,051853582 PubchemFP425 1,46185431
PubchemFP427 1,759641327 PubchemFP428 1,846426958 PubchemFP429 3,544931135
PubchemFP430 3,379433801 PubchemFP431 3,985399855 PubchemFP432 4,547138317
PubchemFP434 4,955938618 PubchemFP435 3,824468546 PubchemFP436 1,406668381
PubchemFP437 3,087977178 PubchemFP438 3,328030389 PubchemFP439 5,098811244
PubchemFP440 3,371711741 PubchemFP441 1,641441249 PubchemFP442 2,830078421
PubchemFP443 4,124533085 PubchemFP445 4,235340814 PubchemFP446 7,803190299
PubchemFP447 3,006462006 PubchemFP448 1,51904661 PubchemFP449 3,147487724
PubchemFP450 4,426407905 PubchemFP451 4,313408275 PubchemFP452 4,296891352
PubchemFP453 3,892483043 PubchemFP454 1,32564735 PubchemFP456 1,603232268
PubchemFP457 2,417281741 PubchemFP458 4,596268258 PubchemFP459 2,105333938
PubchemFP460 1,884428977 PubchemFP461 2,60105 PubchemFP462 3,452725035
PubchemFP464 2,731212656 PubchemFP465 2,697543271 PubchemFP466 3,545236737
PubchemFP467 2,582009855 PubchemFP469 -3,398708243 PubchemFP470 1,017866822
PubchemFP471 3,165212358 PubchemFP472 2,661769675 PubchemFP473 -0,48248963
PubchemFP474 1,517183109 PubchemFP475 -0,354555995 PubchemFP476 2,867624807
PubchemFP477 3,278652607 PubchemFP480 2,671244312 PubchemFP481 1,498522939
PubchemFP482 2,935790523 PubchemFP483 0,515319295 PubchemFP484 1,920114054
PubchemFP485 4,25205125 PubchemFP486 1,370411975 PubchemFP487 4,065647853
PubchemFP489 3,084472626 PubchemFP490 0,580796968 PubchemFP493 4,595630752
PubchemFP494 3,143002119 PubchemFP495 2,073245766 PubchemFP497 2,378332543
PubchemFP498 4,205818662 PubchemFP499 3,476337074 PubchemFP500 3,021393908
PubchemFP501 3,386302732 PubchemFP504 2,14597523 PubchemFP505 0,874517483
PubchemFP506 2,585141176 PubchemFP507 3,147213064 PubchemFP508 3,89216495
PubchemFP509 1,749937259 PubchemFP514 10,8578101 PubchemFP515 4,257585381
PubchemFP516 2,762124916 PubchemFP517 1,351071252 PubchemFP518 0,918565527
PubchemFP519 3,279457996 PubchemFP520 0,086609553 PubchemFP521 1,344152939
PubchemFP523 3,09379198 PubchemFP524 0,68437173 PubchemFP530 2,950498183
PubchemFP531 2,311640845 PubchemFP533 3,484301284 PubchemFP534 2,957503756
PubchemFP535 5,062451829 PubchemFP536 5,534665206 PubchemFP537 3,459472982
PubchemFP538 3,479138091 PubchemFP539 -0,43274116 PubchemFP540 7,264695098
PubchemFP541 2,704938307 PubchemFP543 5,030502599 PubchemFP544 1,966940486
PubchemFP545 1,918594802 PubchemFP547 3,650932127 PubchemFP548 8,931670877
PubchemFP549 1,876087966 PubchemFP550 3,307272233 PubchemFP551 0,809790144
PubchemFP552 1,078056982 PubchemFP553 4,700722058 PubchemFP554 2,119269061
PubchemFP555 2,925741993 PubchemFP556 0,826860807 PubchemFP558 0,74917847
PubchemFP560 5,110426481 PubchemFP563 11,69008325 PubchemFP564 0,080968193
PubchemFP565 2,517460403 PubchemFP566 5,637144883 PubchemFP567 4,402790198
PubchemFP568 3,681791436 PubchemFP569 2,561367378 PubchemFP570 1,887455511
PubchemFP572 2,327700357 PubchemFP573 3,103585815 PubchemFP574 8,637006738
PubchemFP575 3,906413347 PubchemFP577 3,434280609 PubchemFP578 1,253430472
PubchemFP579 4,974276126 PubchemFP580 4,350825551 PubchemFP581 27,9611602
PubchemFP582 1,681736888 PubchemFP583 1,302077708 PubchemFP584 0,604363524
PubchemFP585 1,917250968 PubchemFP586 3,681558892 PubchemFP588 1,779014021
PubchemFP589 2,311423097 PubchemFP591 3,545725403 PubchemFP592 2,227913207
PubchemFP593 3,692339994 PubchemFP594 2,738371646 PubchemFP595 2,030224358
PubchemFP596 2,640274331 PubchemFP597 3,748082056 PubchemFP598 3,2822545
PubchemFP599 2,770113185 PubchemFP600 2,6002304 PubchemFP601 2,926047837
PubchemFP602 5,340688288 PubchemFP603 1,083790777 PubchemFP604 8,873180736
PubchemFP605 2,998808254 PubchemFP606 2,776423494 PubchemFP607 1,535273389
PubchemFP608 2,045482412 PubchemFP609 3,68854547 PubchemFP610 2,766570366
PubchemFP611 3,220448873 PubchemFP612 3,308343548 PubchemFP613 2,864733154
PubchemFP614 3,900336632 PubchemFP615 4,052481121 PubchemFP616 3,214439179
PubchemFP618 0,892978037 PubchemFP619 2,386827311 PubchemFP620 2,093764106
PubchemFP621 2,083110694 PubchemFP622 -2,211401409 PubchemFP623 3,864328125
PubchemFP624 4,178651183 PubchemFP625 3,847376552 PubchemFP626 2,638002847
PubchemFP628 1,824278915 PubchemFP629 2,424761452 PubchemFP630 1,706165914
PubchemFP632 2,284462642 PubchemFP633 3,793120737 PubchemFP634 1,112102323
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PubchemFP636 3,42001581 PubchemFP637 3,579524692 PubchemFP638 3,720332063
PubchemFP639 2,084604434 PubchemFP640 0,834208394 PubchemFP641 3,307970637
PubchemFP642 28,37317767 PubchemFP644 2,465159236 PubchemFP645 6,003074486
PubchemFP646 2,043651855 PubchemFP647 2,320996738 PubchemFP648 0,089614742
PubchemFP650 2,137634745 PubchemFP651 2,623343775 PubchemFP652 2,348846841
PubchemFP653 2,670743772 PubchemFP654 3,54665693 PubchemFP655 3,96546641
PubchemFP656 3,550307079 PubchemFP657 1,967683655 PubchemFP658 5,60002326
PubchemFP659 5,616627598 PubchemFP660 -0,71142259 PubchemFP661 12,16216874
PubchemFP662 2,378482271 PubchemFP664 -0,272578204 PubchemFP665 2,974827701
PubchemFP666 2,818688973 PubchemFP668 1,044766523 PubchemFP669 1,549215762
PubchemFP670 1,831835136 PubchemFP671 4,7873435 PubchemFP673 4,922298182
PubchemFP674 3,275024502 PubchemFP675 2,176488304 PubchemFP676 3,322188622
PubchemFP677 1,008182326 PubchemFP678 0,184241405 PubchemFP679 1,549807243
PubchemFP680 2,533810793 PubchemFP681 6,402521434 PubchemFP682 6,002507529
PubchemFP683 3,055269419 PubchemFP684 5,09083814 PubchemFP685 2,997319401
PubchemFP686 8,749907884 PubchemFP687 7,384540765 PubchemFP688 5,828494223
PubchemFP689 3,299984335 PubchemFP690 4,229656106 PubchemFP691 3,336823487
PubchemFP692 5,498645003 PubchemFP693 6,031396707 PubchemFP694 1,395811294
PubchemFP695 4,289434475 PubchemFP696 4,024892491 PubchemFP697 7,863101091
PubchemFP698 6,635525106 PubchemFP699 4,137553971 PubchemFP700 3,391746725
PubchemFP701 3,707770987 PubchemFP702 3,575388058 PubchemFP703 2,984307521
PubchemFP704 5,069526116 PubchemFP705 3,508552305 PubchemFP706 -1,823278502
PubchemFP707 4,485150787 PubchemFP708 2,362951465 PubchemFP709 3,251570533
PubchemFP710 3,575177439 PubchemFP711 2,794713358 PubchemFP712 3,233427353
PubchemFP713 5,40347963 PubchemFP714 2,02592958 PubchemFP715 1,950547388
PubchemFP716 5,237212708 PubchemFP717 1,942742226 PubchemFP719 2,823975905
PubchemFP721 2,931304177 PubchemFP722 1,692648579 PubchemFP725 0,118438053
PubchemFP728 5,819371228 PubchemFP729 1,872413923 PubchemFP733 1,629328477
PubchemFP734 5,337082078 PubchemFP735 3,521009467 PubchemFP736 1,9599078
PubchemFP737 2,975633098 PubchemFP738 3,522152687 PubchemFP740 2,909986028
PubchemFP742 1,962774021 PubchemFP743 1,390092533 PubchemFP745 0,615838987
PubchemFP746 1,94741773 PubchemFP747 1,443646611 PubchemFP749 2,783839648
PubchemFP750 6,965900675 PubchemFP751 1,644319352 PubchemFP752 1,971222611
PubchemFP755 4,509168769 PubchemFP756 2,309154492 PubchemFP757 3,356086623
PubchemFP758 3,272900182 PubchemFP759 2,126912761 PubchemFP761 1,727962529
PubchemFP762 -2,788624266 PubchemFP763 4,306096212 PubchemFP764 0,797468078
PubchemFP766 1,610017478 PubchemFP767 1,993364349 PubchemFP770 2,175669319
PubchemFP771 5,159418338 PubchemFP772 1,729336143 PubchemFP776 3,574076373
PubchemFP777 2,316310951 PubchemFP778 1,98655155 PubchemFP779 5,146010139
PubchemFP780 2,161756508 PubchemFP782 2,165292143 PubchemFP784 3,109873155
PubchemFP785 2,080134819 PubchemFP788 -0,065853004 PubchemFP791 6,09331101
PubchemFP792 1,884602673 PubchemFP796 2,129760995 PubchemFP797 3,383468658
PubchemFP798 3,729518579 PubchemFP799 1,880799198 PubchemFP800 3,023748874
PubchemFP801 3,818265185 PubchemFP803 3,299252876 PubchemFP805 1,964405158
PubchemFP806 1,157924779 PubchemFP808 0,486156896 PubchemFP809 1,93892923
PubchemFP810 1,472323875 PubchemFP812 2,807882462 PubchemFP813 6,900219219
PubchemFP814 1,900581668 PubchemFP815 1,874921751 PubchemFP818 5,12807583
PubchemFP819 3,801071966 PubchemFP820 2,853649623 PubchemFP821 3,292301438
PubchemFP822 2,303791526 PubchemFP824 2,331609804 PubchemFP825 -2,082496566
PubchemFP826 4,276495838 PubchemFP827 1,461280819 PubchemFP829 1,838977891
PubchemFP830 2,210479593 PubchemFP833 2,548097339 PubchemFP834 5,203282609
PubchemFP835 1,945918279 PubchemFP839 1,337134286 PubchemFP840 -2,583902923
PubchemFP860 -2,347280754 PubchemFP861 -2,46705644 nAcid 3,332081242
apol 7,397373918 naAromAtom 11,74694985 nAromBond 11,4684336
nAtom 7,2529769 nHeavyAtom 5,259682055 nH 16,39710999
nB 9,575708041 nC 11,12802273 nN 8,839979384
nO 9,638108827 nS 5,585545547 nP 1,710920882
nF 8,47355966 nCl 6,70769428 nBr 1,780929151
nI 3,619785573 ATSc1 11,72103653 ATSc2 17,8538851
ATSc3 28,54495272 ATSc4 19,96408713 ATSc5 20,06291788
ATSm1 11,21852329 ATSm2 7,44021864 ATSm3 5,82230879
ATSm4 9,923189169 ATSm5 9,901599117 ATSp1 7,459706434
ATSp2 7,60387196 ATSp3 8,5166431 ATSp4 10,31620231
ATSp5 9,085094685 nBase 9,259139652 nBonds 5,539070583
nBonds2 8,839371577 nBondsS 7,842189569 nBondsS2 8,108908035
nBondsS3 9,394517358 nBondsD 10,11982319 nBondsD2 10,51460108
nBondsT 3,415922543 bpol 7,499026382 C1SP1 3,314858487
C2SP1 2,060077231 C1SP2 10,80477492 C2SP2 15,89893105
C3SP2 15,58708099 C1SP3 11,80770938 C2SP3 11,30300554
C3SP3 6,873386489 C4SP3 6,04992395 SCH.3 2,507347999
SCH.4 6,469188021 SCH.5 13,14783506 SCH.6 17,96205057
SCH.7 15,82997014 VCH.3 2,719564999 VCH.4 7,303959982
VCH.5 15,19849046 VCH.6 12,87316705 VCH.7 23,55994181
SC.3 12,04145508 SC.4 14,00599383 SC.5 7,383570865
SC.6 11,8610675 VC.3 10,83903348 VC.4 21,84588415
VC.5 14,93723049 VC.6 11,37794061 SPC.4 9,580457638
SPC.5 13,07353486 SPC.6 9,08862701 VPC.4 9,638926115
VPC.5 9,670087183 VPC.6 9,535915933 ECCEN 9,649229452
fragC 14,87946664 nHBAcc 7,168215635 nHBAcc2 7,134828175
nHBAcc3 16,35565225 nHBAcc_Lipinski 6,503030978 nHBDon 31,42144542
nHBDon_Lipinski 9,664117003 nAtomLC 11,80361895 nAtomP 11,39901697
nAtomLAC 12,64567921 MLogP 23,40030942 McGowan_Volume 9,279004335
MDEC.11 7,888492134 MDEC.12 11,00859844 MDEC.13 13,65455131
MDEC.14 10,42887048 MDEC.22 18,30938998 MDEC.23 10,69907753
MDEC.24 13,69904338 MDEC.33 17,65236065 MDEC.34 16,21610379
MDEC.44 4,247316136 MDEO.11 18,54133766 MDEO.12 38,35723776
MDEO.22 5,161496335 MDEN.11 9,259706793 MDEN.12 8,763776733
MDEN.13 28,42443718 MDEN.22 13,40163382 MDEN.23 8,311805906
MDEN.33 9,272423975 MLFER_A 12,54818716 MLFER_BH 13,26045329
MLFER_BO 18,27897289 MLFER_S 13,46270908 MLFER_E 14,21338674
MLFER_L 22,05257189 PetitjeanNumber 13,81155272 nRing 4,687561127
n3Ring 1,821278134 n4Ring 0,948640063 n5Ring 7,993345974
n6Ring 13,20644912 n7Ring -0,434223307 n8Ring -2,944398907
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n9Ring -0,181328412 n10Ring 1,26287563 nG12Ring 1,980471213
nFRing 7,77362455 nF6Ring 0,339097763 nF8Ring 0,761810914
nF9Ring 6,584906595 nF10Ring 8,550225307 nF11Ring 2,192974805
nF12Ring 3,0718827 nFG12Ring 4,769270186 nTRing 7,905911957
nT4Ring 0,937080721 nT5Ring 7,967636357 nT6Ring 13,1341923
nT7Ring -0,757553318 nT8Ring 1,720740882 nT9Ring 6,755727742
nT10Ring 8,717981457 nT11Ring 2,168133585 nT12Ring 3,227169333
nTG12Ring 4,868991532 nRotB 11,34629835 TopoPSA 15,2831086
VAdjMat 5,539727381 MW 12,34151936 WTPT.1 7,35349285
WTPT.2 12,98955477 WTPT.3 10,86242205 WTPT.4 16,41680473
WTPT.5 14,67650623 WPATH 16,3545136 WPOL 8,653764565
Zagreb 8,046209245 X533 2,689047064 X131 6,043162967
X486 2,194357265 X93 3,629466182 X28 3,714148992
X282 2,932288034 X429 2,816670947 X292 2,784258921
X716 2,679971733 X893 2,180345559 X564 3,658207578
X490 2,34918716 X132 7,083041069 X442 4,207258425
X327 4,542205223 X90 2,521110405 X333 6,868836084
X562 3,219728746 X51 3,085486643 X390 7,126369427
X693 4,629926703 X346 6,827906131 X686 3,072518304
X779 3,02187265 X27 2,909601895 X569 5,04697968
X687 2,372636581 X128 5,605741997 X218 5,656526873
X430 2,508314463 X859 2,677560743 X415 5,129922605
X541 3,649699997 X269 3,640523129 X898 5,667581821
X258 3,076320528 X13 3,854120359 X384 4,456409957
X409 4,088032907 X580 2,777753994 X263 4,221398588
X426 4,064737459 X531 2,780034551 X575 3,133133375
X519 2,577781002 X189 2,158220581 X553 3,108110035
X818 4,340217861 X559 7,081057781 X407 4,947733202
X37 3,017472932 X708 4,736635964 X462 3,729512377
X764 2,647017612 X681 2,543338429 X160 3,235457006
X222 3,791156354 X45 6,969980206 X735 3,740496858
X800 2,707683438 X100 2,129745411 X416 3,240349902
X444 4,610706093 X107 5,064144649 X115 3,225509011
X913 3,023999989 X599 4,203985076 X241 4,174981356
X202 5,015508259 X551 3,504476424 X560 2,87391391
X361 5,226020953 X583 3,442226621 X493 2,644005181
X1 1,944626606 X5 4,974526286 X58 4,056335883
X249 4,594272575 X641 3,77309247 X141 3,558112952
X809 3,980875158 X793 0,465929656 X633 2,932972595
X622 2,665660401 X59 16,47605452 X577 2,623446072
X875 4,36391711 X145 3,736249754 X613 4,663459656
X827 2,709032745 X607 3,689911713 X871 3,806570926
X592 2,55192084 X423 4,799355507 X322 3,126660535
X495 2,983664063 X658 2,580888199 X369 3,593170963
X804 3,340600555 X103 2,441607061 X268 3,629364244
X826 4,995576544 X122 2,830337231 X422 3,769586012
X452 2,515616971 X363 2,946411007 X579 2,291786064
X909 3,91543789 X786 3,574552504 X568 4,522787221
X769 2,900454829 X840 2,945448536 X889 3,261406163
X825 3,382508811 X75 2,745853492 X555 9,956459772
X498 3,535725447 X38 3,44731556 X167 5,519371036
X480 2,736281389 X275 5,227795285 X783 3,176227661
X19 2,340273676 X801 3,132050459 X114 4,240445921
X270 2,980343527 X54 4,715852152 X405 4,072777026
X849 3,011271487 X304 3,855850168 X299 2,995618905
X731 2,683201233 X193 10,92432422 X532 2,399844935
X198 3,158618236 X710 2,36097675 X417 4,954457077
X305 4,376629625 X272 5,021129076 X721 4,4005475
X864 4,635029204 X703 3,788200327 X732 3,323586499
X391 4,65549171 X759 2,494151998 X97 2,523903747
X497 2,650877703 X459 2,827014055 X311 4,532187412
X905 2,688523664 X335 2,385905701 X180 3,950908682
X18 6,738851395 X887 4,069302286 X744 3,080414486
X211 2,78796696 X205 4,014581693 X91 2,594762671
X356 4,015826449 X194 4,074340973 X830 2,996632668
X799 3,994560906 X520 2,469545074 X352 4,616571089
X861 3,112967316 X184 3,346007416 X509 2,311182947
X223 2,771326145 X22 3,511676346 X8 2,726095979
X762 2,791248083 X637 2,466434058 X829 4,881767784
X159 2,780708667 X576 2,51532598 X790 4,495072022
X892 3,13642764 X665 2,525685216 X885 5,457031425
X48 2,468495141 X788 2,439646512 X803 3,941464909
X379 2,684597367 X432 3,433967214 X798 4,02791627
X770 3,176729383 X228 3,50510575 X257 3,219861336
X844 3,622368283 X71 3,139157078 X860 2,937426203
X171 3,444339492 X726 3,183132321 X151 4,212457287
X857 3,24071417 X886 4,399191421 X868 3,279251388
X872 2,323844849 X567 3,059196583 X220 3,145317781
X40 8,470149559 X341 4,848236814 X910 4,727220666
X736 4,821455029 X440 6,75685441 X877 2,997863238
X50 3,32658302 X660 3,110187804 X154 3,210621177
X719 2,703335535 X673 3,222316132 X169 3,173494362
X745 6,196082921 X146 3,920771395 X791 1,854921906
X425 3,266740542 X454 2,961292974 X517 2,668111988
X604 2,720535615 X645 3,365581639 X108 3,13534011
X904 3,349401575 X620 2,566311859 X420 3,861963174
X661 3,087384224 X226 2,957510804 X571 3,118509017
X362 2,477615187 X153 2,46873442 X806 2,502745902
X915 2,58935681 X276 5,085615334 X204 3,443713818
X178 2,912510098 X183 3,286648737 X364 3,224758993
X315 9,240138069 X496 4,390752217 X526 3,3113364
X436 3,589499828 X513 2,260605764 X300 3,882119994
X460 2,634503898 X31 5,774634076 X891 2,53472356
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X469 2,749811947 X853 4,179577519 X324 3,797532131
X743 3,236892375 X651 2,727355791 X89 2,480529072
X181 3,879926472 X49 4,472035446 X15 4,539076189
X366 7,136719308 X457 3,110101945 X695 2,969079594
X371 4,666421933 X113 2,813135562 X503 2,713593724
X663 5,755929627 X834 3,737314991 X212 2,662243495
X856 2,973607357 X284 5,981096986 X808 2,546903689
X56 5,335878654 X224 4,116188345 X357 2,552824104
X862 3,185480196 X488 2,155385633 X96 3,540507257
X612 5,006468061 X802 3,461150849 X157 2,555476516
X707 3,091511772 X724 4,319012615 X574 2,221793984
X129 3,46854724 X466 2,510998479 X771 3,899617344
X547 2,890280634 X676 3,885309188 X372 3,194753576
X267 4,087640484 X6 3,503700394 X510 2,031179526
X652 2,975560033 X265 10,98824577 X487 2,56333188
X155 2,498893047 X494 2,703782759 X590 4,113435018
X881 3,556294205 X754 2,417877961 X147 2,763305087
X427 2,281110876 X655 3,504647365 X370 4,108362136
X884 1,996136171 X846 3,105157532 X833 3,660816228
X593 3,04202858 X698 3,259984818 X441 3,964314536
X377 4,606312955 X235 3,566278078 X404 3,87006467
X539 2,374446376 X717 3,886049845 X631 2,764723063
X614 5,83255618 X101 3,438431626 X691 5,812366025
X439 4,235180486 X843 3,348522353 X749 2,380025092
X25 3,088495325 X761 2,750548396 X899 3,811522201
X774 3,281936682 X820 3,69149935 X289 2,215833178
X136 3,072503814 X476 2,289342756 X336 2,971453555
X483 2,905115761 X26 3,632504973 X83 2,319676563
X456 4,117866778 X505 2,902759917 X260 6,388815856
X144 3,31990361 X174 2,63075613 X368 2,447030247
X634 2,730569204 X453 2,347998968 X643 3,150496472
X545 3,955163354 X246 3,194773259 X540 2,239068124
X400 7,036250361 X296 3,033558984 X321 1,952629168
X112 4,108604605 X85 2,532657743 X720 7,777442278
X435 4,301274028 X250 3,960018258 X582 2,565115843
X360 3,117790793 X831 4,627194068 X254 3,815207661
X474 2,517831672 X669 4,127674677 X374 4,079633018
X342 3,800106978 X323 3,435175266 X624 3,393421075
X124 2,899127644 X527 2,777063339 X572 5,72964678
X475 2,239081419 X556 3,482354828 X216 3,981100478
X240 3,721422181 X399 4,370984852 X331 6,520776183
X566 4,579031856 X598 4,392444041 X699 2,551250526
X521 3,685002201 X588 3,354791305 X210 2,878691078
X753 2,412914948 X878 3,545874497 X756 2,713620154
X741 2,824426696 X882 3,06341744 X102 4,248268374
X611 2,586483484 X679 4,276386046 X256 3,365696324
X478 2,526960398 X344 3,957795559 X740 1,671548371
X229 5,149180935 X383 5,074108433 X773 3,419300761
X35 2,374885691 X775 2,730948353 X838 3,838182774
X565 3,493091888 X0 1,497395152 X455 3,899635522
X586 2,144647541 X69 4,523672613 X355 2,757366835
X388 3,856590647 X814 3,149862101 X748 2,950916848
X227 3,62948851 X778 3,236247678 X21 3,550076037
X401 11,6840971 X796 3,536112065 X570 3,078290374
X373 4,068183922 X408 3,993568998 X819 3,002318339
X601 3,808689288 X62 4,944435765 X403 5,005342165
X421 3,351519268 X578 3,121484521 X4 5,407242557
X365 4,362742815 X528 2,749722486 X133 4,739913803
X714 3,720441266 X608 5,79388447 X851 1,947519588
X522 2,27151853 X412 3,77953925 X14 3,521730058
X280 3,773857613 X697 2,948367922 X84 4,020389431
X176 2,772708834 X332 6,593052101 X727 3,696560188
X777 3,354606777 X696 2,750037391 X789 4,370963139
X646 2,378820436 X689 4,24546232 X319 3,202941973
X126 3,610487914 X111 9,684872842 X890 2,948661841
X758 2,591851386 X534 3,255715816 X53 3,177900383
X308 6,088776591 X448 3,42168043 X367 2,708195847
X301 5,80778538 X589 3,571720711 X434 3,604145057
X894 5,300973999 X671 3,064578169 X516 5,831171602
X591 3,243469461 X837 4,210887264 X461 4,766532999
X780 3,219844278 X92 5,514237162 X117 2,445364139
X99 2,124450637 X60 3,75792382 X847 3,478023253
X314 5,778057015 X606 2,861860938 X842 2,669483844
X350 3,253400696 X243 5,562273558 X538 2,368145865
X471 2,209659568 X203 3,72817277 X595 2,591383262
X867 3,485031216 X805 4,07907645 X162 3,428091022
X874 5,544028603 X836 3,890539366 X152 3,901786718
X479 2,298060165 X668 4,233096106 X512 2,758251617
X546 2,831551083 X419 4,118563977 X221 2,6111164
X33 11,27343702 X738 2,561186912 X502 2,436646444
X207 2,926854943 X130 5,003508725 X120 3,311803519
X561 2,841406221 X596 3,061964074 X278 6,677045331
X86 2,212189099 X458 3,976452605 X135 4,579024698
X382 3,020968024 X206 3,499518928 X307 8,730730774
X137 4,119310921 X47 4,197246297 X468 3,410002387
X737 3,775760328 X543 3,568661305 X537 2,895530101
X438 4,165108518 X16 4,023766692 X316 2,853112285
X42 5,112505167 X392 2,874073579 X597 4,475917146
X573 3,784940826 X616 2,772284374 X811 3,609278462
X558 5,658484952 X855 2,877467283 X584 2,046289507
X290 2,330103236 X73 3,373180554 X850 2,242081436
X303 2,97633267 X381 3,474993806 X196 2,903540869
X199 3,252871162 X845 2,719259903 X626 3,66766951
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X402 2,545485933 X659 7,175326048 X179 3,887994648
X654 3,891917633 X870 3,085676013 X896 2,28289105
X623 3,659819191 X914 2,910087085 X127 3,893975714
X835 2,045784136 X328 2,988707725 X628 4,080891343
X340 3,078619959 X214 3,547696429 X233 2,79980451
X286 3,525299022 X345 2,653244604 X883 1,705356694
X482 3,312790186 X832 3,245122213 X649 2,976902638
X902 4,237953743 X734 3,527720034 X248 3,938069631
X76 4,495876205 X186 4,05605175 X279 3,455408658
X472 2,759004275 X666 2,468067583 X866 2,470004239
X329 3,555982804 X767 2,680742246 X785 3,336295962
X433 2,890544412 X118 2,017476378 X817 3,663341765
X44 4,82821855 X694 2,665674964 X752 4,359348674
X349 3,502838301 X67 6,6251809 X217 3,298598391
X863 3,594910661 X283 3,388935988 X713 4,839686371
X337 3,93156485 X766 2,839392649 X138 3,772175994
X262 3,235244738 X288 3,779103299 X358 4,112157089
X32 2,547079651 X879 2,576673987 X123 2,70456457
X389 4,764929235 X291 2,200541353 X215 3,520349017
X317 4,739901677 X554 3,412864107 X109 3,129044146
X106 6,768093704 X156 2,404871057 X841 3,325393942
X29 3,15995143 X852 4,014219717 X318 5,987959501
X353 3,516282855 X544 3,61502478 X348 3,646036226
X242 3,691029514 X166 5,591903101 X338 3,527916197
X201 4,931232765 X848 3,068683233 X281 5,503499383
X431 3,761082402 X293 2,384300334 X746 3,220365873
X680 2,17364781 X376 5,370459068 X393 3,360893393
X470 2,628295464 X712 2,305336005 X386 2,94636611
X715 6,755482105 X9 3,31261383 X310 3,350790125
X656 2,794389055 X177 2,945090724 X326 3,142928008
X81 7,656274651 X375 3,839923109 X742 3,32370589
X815 2,869974894 X763 2,594579821 X253 3,556739172
X20 2,282161295 X858 -0,099287679 X396 2,225400965
X418 4,195179418 X200 4,51145313 X149 3,49727543
X644 2,71461831 X822 2,519367524 X816 2,29032894
X163 3,436627457 X865 2,607011986 X23 3,045898683
X615 3,809319408 X185 4,160457034 X636 3,068494098
X916 2,381414491 X320 3,511104286 X705 3,675467781
X87 3,876489825 X230 3,667477771 X36 2,329502143
X24 2,973820888 X164 3,242043109 X895 6,741618599
X34 2,577620274 X273 3,271442342 X231 3,576490835
X445 10,71501927 X610 2,621243483 X380 3,700585544
X617 3,109337026 X43 4,408085563 X722 4,153864841
X7 2,850733759 X706 2,414336492 X797 3,852055378
X406 5,646045139 X140 3,285322286 X662 2,964338305
X94 4,618131143 X266 3,204438067 X869 3,534137846
X251 3,156702369 X190 2,508360656 X236 3,495408289
X339 2,412837554 X46 3,719177432 X912 1,773675447
X347 5,500468692 X747 3,869627065 X485 3,035153492
X675 2,690657706 X39 2,96710781 X312 4,944192771
X621 3,051824309 X261 3,794700623 X701 2,571543944
X464 2,153341501 X704 3,934657878 X451 4,475399857
X552 3,244560483 X529 2,4006832 X287 4,937626862
X600 4,075710886 X484 2,620628066 X667 2,498671311
X446 2,838786229 X603 3,850362636 X175 3,325368588
X134 3,486067827 X897 6,734342353 X295 2,222332546
X244 5,565704639 X670 5,243623415 X302 2,958248796
X625 4,047373994 X492 2,637411122 X121 2,549661269
X810 4,086959202 X648 2,245670126 X30 3,008216557
X511 2,479494722 X70 3,177041656 X491 2,544303427
X397 4,930029386 X57 6,723947797 X95 6,155027355
X168 3,911509092 X500 2,134849259 X765 3,086567478
X638 2,968775137 X506 2,804697069 X781 3,260990091
X602 3,933193402 X150 4,153514926 X682 2,663075416
X125 3,196999513 X594 5,222373202 X911 4,094140533
X225 2,889044972 X239 3,877252928 X192 1,880124712
X271 1,861960082 X394 2,893010874 X733 3,844878265
X182 3,961449946 X702 2,847936684 X709 2,330584681
X918 3,631028246 X585 2,000659 X750 3,956567233
X605 3,148960324 X550 3,534067619 X172 3,809972005
X143 2,935422183 X105 5,939052001 X787 4,724354006
X535 3,773846147 X255 3,841566492 X501 3,914479694
X755 2,57104101 X684 3,211268604 X813 3,441891772
X548 2,652120598 X2 1,742988097 X792 -0,654768194
X903 4,027234108 X351 3,442910845 X876 4,001626959
X395 5,375332449 X17 4,740838664 X473 2,472069119
X630 3,400415279 X443 3,880139417 X238 3,537616387
X306 5,187703233 X657 2,850552409 X247 3,401216147
X772 3,184440746 X839 3,758874733 X72 2,461611213
X812 3,752438017 X782 5,322749 X795 2,600630065
X187 3,461499081 X139 3,769187433 X690 4,974328657
X245 2,444992945 X807 3,121235199 X12 4,237847464
X74 4,073944673 X725 1,608854189 X188 1,893743541
X700 2,705385198 X692 2,926932332 X647 2,384226839
X82 3,236226721 X536 2,532117237 X294 2,366539831
X784 2,523571354 X518 3,30571065 X760 2,264566218
X465 2,386151598 X672 3,078648577 X907 3,837916958
X901 4,175359949 X285 5,957438395 X557 2,664903276
X219 6,310831132 X10 2,81584965 X674 2,814811602
X627 4,342414965 X88 4,459082976 X632 2,499284648
X908 6,396270638 X823 3,543899457 X313 4,856944892
X729 4,890202322 X232 3,627094014 X489 2,243748972
X78 3,134877137 X609 2,650022829 X387 4,377534083
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X530 2,106519393 X264 4,396978685 X507 2,60290901
X80 3,820049004 X437 6,919411578 X678 4,705498876
X66 3,828169123 X508 2,728482169 X587 2,709595345
X161 4,41611935 X428 3,349896614 X650 2,96724215
X411 4,646934127 X104 2,366747946 X664 5,852769383
X524 2,752495333 X334 2,045201526 X685 8,081478168
X683 3,282334105 X325 4,667618549 X277 6,514638543
X110 5,342806208 X549 4,236975576 X424 3,809621427
X148 3,063205261 X514 2,401961129 X79 2,613096129
X619 3,126884402 X880 3,358138938 X259 2,716526934
X3 6,500663058 X776 3,428393283 X581 2,803904946
X41 6,462588211 X906 4,112510474 X635 2,518781416
X677 2,600264525 X919 5,329322448 X467 3,060254569
X450 2,877138402 X723 3,064849439 X449 3,41372239
X477 2,538887557 X64 2,716907456 X413 3,172948811
X173 2,716414864 X158 3,076842963 X525 2,434330858
X274 2,837083426 X234 4,170068147 X504 2,537162077
X116 3,02784115 X854 3,818041358 X98 2,323180853
X191 1,83134962 X688 3,691669095 X237 3,950278274
X252 3,828770315 X888 4,162262152 X119 4,209927633
X618 2,970663405 X213 3,755769507 X542 3,628299617
X165 3,892431836 X873 2,849401028 X523 4,01564681
X821 2,982564937 X718 2,566221544 X629 5,311617851
X354 3,580378535 X653 3,01043356 X208 3,382548405
X447 3,629212369 X170 3,849249032 X463 3,267575848
X642 3,23111047 X142 3,888315367 X730 3,575449908
X515 2,95294099 X343 5,308755236 X639 3,151953364
X65 4,314207254 X63 3,127518976 X11 3,869142988
X640 2,692514838 X209 2,705220793 X298 2,692445379
X330 4,549952853 X297 2,830117356 X824 1,784772204
X195 5,010873957 X900 15,77879541 X385 2,642611008
X414 5,450081611 X828 3,864505132 X751 3,26746318
X739 2,670088286 X55 2,760822073 X768 2,199370587
X68 2,632319294 X52 2,817392739 X499 3,740822506
X917 6,628455558 X378 4,39843773 X359 4,006998315
X410 4,766380121 X398 3,561190917 X61 3,975698256
X309 4,77683088 X563 7,617578564 X77 3,043480519
X728 2,02497137 X794 1,894753296 X197 3,085823206
X711 2,920723278 X757 2,639831737
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Appendix E
Feature importance for one fold in the
replication performed
Feature %IncMSE Feature %IncMSE Feature %IncMSE
MS.HL 63.030802095337 AKT2_cn 15.5944570109132 ALK_wt 1.7995286469141
APC_wt 51.6808498904511 APC_cn 10.4709345146404 BRAF_wt 133.609599865903
BRAF_cn -0.356927579747502 BRCA1_wt 26.1892314416616 BRCA2_wt 3.6351528948809
BRCA2_cn 0.144166288185375 CCND1_cn 31.7505936438385 CCND2_cn 27.1913512687925
CCND3_cn 0.112519326209813 CDH1_wt -20.389234925535 CDH1_cn 10.4039287699489
CDK4_cn 15.4450345132938 CDK6_cn -6.97465697925511 CDKN2A_wt 122.168537937684
CDKN2A_cn 134.559803938746 CDKN2C_wt 3.70554542329518 CDKN2C_cn 14.09721518872
CDKN2a.p14._wt 154.198440218973 CTNNB1_wt 19.3315323455614 CTNNB1_cn 14.8825579126525
CYLD_wt 3.01170183363915 EGFR_wt 5.24854272995059 EGFR_cn -13.6234880523058
EP300_cn 15.1159710814059 ERBB2_wt 7.31434498983231 ERBB2_cn 56.2161801617159
EZH2_wt -18.2199215052158 EZH2_cn 0.0293511992847435 FAM123B_wt 14.9641852744136
FAM123B_cn 12.2189309382264 FBXW7_wt 32.039180555225 FBXW7_cn 3.44306779276597
FGFR2_cn 30.5273389366171 FGFR3_wt 11.586452237742 FGFR3_cn 10.5450103493052
FLCN_wt 3.06406316035099 FLT3_wt 5.222034146487 FLT3_cn -0.918992968050054
GNAS_wt 23.4765747385554 GNAS_cn 10.9797220575091 HRAS_wt -24.0405580080076
IDH1_wt 16.7705293751201 IDH1_cn 7.83003498191086 JAK2_wt 10.7993478309974
JAK2_cn -2.8236868117502 KDM5C_wt 7.3695414635145 KDM5C_cn -0.93844790088401
KDM6A_wt 18.4310850418543 KDM6A_cn -1.73537172805421 KDR_cn 8.90065886863179
KIT_cn 13.6368894063793 KRAS_wt 102.893368963218 KRAS_cn -17.9162712942346
MAP2K4_wt 11.0823719021441 MAP2K4_cn 4.02583849026277 MDM2_cn 33.7320988208828
MET_cn 18.5785936682867 MLH1_wt 56.8877905521721 MLH1_cn 7.07995632988188
MLLT3_cn -13.6973756182997 MSH2_wt -6.50901792897395 MSH2_cn 3.6961685057127
MSH6_wt -7.80250627512262 MSH6_cn 7.38980159212067 MYC_cn 29.5648063247257
MYCL1_cn 6.89120795047741 MYCN_cn 35.6088423704808 NF1_wt 26.874611205512
NF1_cn -2.53422075484848 NF2_wt 41.6774208038113 NF2_cn 12.1074031513538
NOTCH1_wt 36.5730415370446 NRAS_wt 52.8589213170972 NRAS_cn 21.8701033091377
PDGFRA_cn -16.4232965164592 PIK3CA_wt 43.8555270689856 PIK3CA_cn 21.6705918990256
PIK3R1_wt 25.9892237549616 PIK3R1_cn 15.3816181805634 PTEN_wt 61.9079055825935
PTEN_cn 53.8248669431963 RB1_wt 33.6458614785392 RB1_cn 2.02301926322838
RUNX1_wt 10.7548728340524 SETD2_wt -14.1359033254016 SMAD4_wt 111.197026628522
SMAD4_cn 1.53439590654189 SMARCA4_wt 14.4325800708993 SMARCA4_cn -4.29663440852717
SMARCB1_cn -6.87226915527052 SMO_cn -2.39666286216357 SOCS1_cn -0.255989690729639
STK11_wt 52.3333522918816 STK11_cn 4.26985928256955 TET2_wt 39.482823904137
TP53_wt 60.9882620382466 TP53_cn 2.26316427755261 TSC1_wt 22.7790708292619
TSC1_cn 12.0933316735095 VHL_wt 14.8040232426642 VHL_cn 16.3108288684174
WT1_cn 6.65157991583468 PubchemFP0 5.39288697709807 PubchemFP1 1.5446031270372
PubchemFP2 -1.77972333038301 PubchemFP6 8.84413888340566 PubchemFP9 0.868401836969371
PubchemFP10 2.49556635136749 PubchemFP11 1.45294688616572 PubchemFP12 2.50721861126388
PubchemFP13 1.86596520618869 PubchemFP14 3.4672351672435 PubchemFP15 4.55177127958497
PubchemFP16 5.08906457968508 PubchemFP17 2.19146711852432 PubchemFP18 3.24370397568824
PubchemFP19 7.2573600663377 PubchemFP20 6.94433117218408 PubchemFP21 1.25996663183254
PubchemFP22 2.65606641304926 PubchemFP23 9.4182492005021 PubchemFP24 6.95477874511905
PubchemFP25 3.52451893668916 PubchemFP30 1.44870839033914 PubchemFP33 4.40305791627611
PubchemFP34 5.05741216626264 PubchemFP37 5.45253293741407 PubchemFP38 5.40059446571981
PubchemFP43 1.50330885675088 PubchemFP44 2.01560458319998 PubchemFP46 4.77065189765585
PubchemFP93 3.88433359113152 PubchemFP115 2.83712082578723 PubchemFP116 2.818701183711
PubchemFP117 -0.686177687322741 PubchemFP118 -1.81090964529685 PubchemFP129 0.831293692484912
PubchemFP130 0.352518730536206 PubchemFP132 -1.2187245040104 PubchemFP143 4.34649972961588
PubchemFP144 3.07076453164156 PubchemFP145 6.35720966361323 PubchemFP146 6.48600224058122
PubchemFP147 -3.3945566625045 PubchemFP148 6.94921425063049 PubchemFP149 5.65035199268905
PubchemFP150 5.05684588462767 PubchemFP152 5.43959180748051 PubchemFP153 4.09270614497437
PubchemFP155 5.97871491011471 PubchemFP156 5.80646512950928 PubchemFP157 9.01332197364307
PubchemFP159 2.25564349555199 PubchemFP160 2.90367920340759 PubchemFP164 1.79048951623869
PubchemFP167 1.60074228623241 PubchemFP178 12.7933050967614 PubchemFP179 2.82517545386095
PubchemFP180 7.61527716222515 PubchemFP181 7.03649332722284 PubchemFP182 6.08408845074705
PubchemFP183 3.89790805057656 PubchemFP184 5.4879003455738 PubchemFP185 2.59084758557437
PubchemFP186 3.91759982639011 PubchemFP187 15.152462944287 PubchemFP188 12.5749090751241
PubchemFP189 1.08434370664216 PubchemFP190 -5.93513622311873 PubchemFP191 3.46772106624199
PubchemFP192 5.48463086995993 PubchemFP193 7.23279900664838 PubchemFP194 6.59201497003662
PubchemFP195 3.11477408860776 PubchemFP199 4.37744797771988 PubchemFP200 3.01007733515858
PubchemFP206 5.98406765315526 PubchemFP213 1.14174431201675 PubchemFP214 -5.245803004306
PubchemFP218 1.65651656254834 PubchemFP219 2.15786895338216 PubchemFP227 -6.43754828402522
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PubchemFP228 1.04104769696486 PubchemFP232 -5.40733265547834 PubchemFP233 -4.48020160320187
PubchemFP241 -0.309631920489828 PubchemFP246 -0.66358207196537 PubchemFP247 0.613054065054675
PubchemFP248 1.55389450337808 PubchemFP252 0.468147748180114 PubchemFP255 2.04262338381516
PubchemFP256 4.75849751635205 PubchemFP257 4.28958192856559 PubchemFP258 8.0276761466956
PubchemFP259 3.79347625438562 PubchemFP260 4.07398400367559 PubchemFP261 5.33490916421802
PubchemFP262 1.63659442904341 PubchemFP274 8.06261425076962 PubchemFP276 7.76047367282502
PubchemFP283 1.60905326675799 PubchemFP284 3.01421091124859 PubchemFP285 2.64768597297803
PubchemFP286 3.75600175647762 PubchemFP287 10.4457054833001 PubchemFP293 2.37532521308849
PubchemFP294 6.05999138561047 PubchemFP297 3.03728065282046 PubchemFP298 5.45869320730233
PubchemFP299 5.94754786491798 PubchemFP300 5.23054548924839 PubchemFP301 10.7432827788657
PubchemFP305 3.29972775503794 PubchemFP308 7.9083341983648 PubchemFP314 1.88542563087457
PubchemFP327 2.78534561737192 PubchemFP328 2.68070980858481 PubchemFP330 2.8442205367358
PubchemFP332 1.77739106796962 PubchemFP333 2.10856848150883 PubchemFP334 5.69846155054877
PubchemFP335 2.93716647790619 PubchemFP336 5.18809360329488 PubchemFP337 21.1251791965691
PubchemFP338 4.81422972301471 PubchemFP339 5.48105195600646 PubchemFP340 4.16638593761856
PubchemFP341 6.68302203020198 PubchemFP342 4.99261999516781 PubchemFP344 2.14634715556342
PubchemFP345 5.73822594267683 PubchemFP346 8.52441184206974 PubchemFP347 2.64672171074501
PubchemFP349 6.80400799706548 PubchemFP350 4.44717872920241 PubchemFP351 3.38293454002848
PubchemFP352 2.95944392670927 PubchemFP353 4.65468188773278 PubchemFP355 1.8498267391067
PubchemFP356 4.13989013800825 PubchemFP357 5.7046958832579 PubchemFP358 3.89575617906114
PubchemFP359 4.89902647004964 PubchemFP360 0.185821847949988 PubchemFP362 6.86403135012526
PubchemFP363 4.18841439903335 PubchemFP364 5.3571718471372 PubchemFP365 4.55400386698942
PubchemFP366 6.30565784696109 PubchemFP367 3.08541076614299 PubchemFP368 2.40238208503982
PubchemFP370 2.922051951852 PubchemFP371 1.43875205889835 PubchemFP372 5.10146453680511
PubchemFP373 5.0618103882342 PubchemFP374 9.34453525209538 PubchemFP375 6.56995784404531
PubchemFP376 2.94850225055982 PubchemFP377 9.02423513632515 PubchemFP378 4.03130837456457
PubchemFP379 2.47902998255392 PubchemFP380 1.90460914431438 PubchemFP381 3.95031032453805
PubchemFP382 2.39693902860443 PubchemFP383 2.52443220147329 PubchemFP384 1.67475596436154
PubchemFP385 4.07565714256484 PubchemFP386 8.37096375291921 PubchemFP387 3.82817300792413
PubchemFP388 3.5096507318583 PubchemFP389 3.91221038429244 PubchemFP390 3.32322129843472
PubchemFP391 5.62159289206657 PubchemFP392 6.07640028177484 PubchemFP393 5.38158778472045
PubchemFP394 3.18109328906227 PubchemFP395 11.3325386869067 PubchemFP396 2.91467294561337
PubchemFP397 3.20551936854935 PubchemFP398 3.97116879407602 PubchemFP399 3.13388110685478
PubchemFP400 3.93356858037794 PubchemFP403 4.67727361133478 PubchemFP404 1.29698602796767
PubchemFP405 5.1275429224587 PubchemFP406 5.76126229081497 PubchemFP407 1.63067743756927
PubchemFP408 3.59526742419134 PubchemFP409 1.81984392142365 PubchemFP411 1.94010970209228
PubchemFP412 3.8459382770605 PubchemFP413 2.68491324709903 PubchemFP414 1.36712403274931
PubchemFP416 1.73551193673471 PubchemFP417 2.88996909145362 PubchemFP418 3.34797915473963
PubchemFP419 4.31854535910808 PubchemFP420 5.87355239964331 PubchemFP421 3.20878529544321
PubchemFP422 4.65259373476886 PubchemFP423 2.69567671270907 PubchemFP425 1.94409055979521
PubchemFP427 2.95093349051344 PubchemFP428 1.88098220171213 PubchemFP429 4.0483558367319
PubchemFP430 4.56822504711882 PubchemFP431 5.37273369196822 PubchemFP432 6.77467026410277
PubchemFP434 6.12099386042609 PubchemFP435 4.65398944866572 PubchemFP436 1.60713451827923
PubchemFP437 6.70440779707276 PubchemFP438 4.17570827001739 PubchemFP439 9.33022128672683
PubchemFP440 3.84564109266531 PubchemFP441 1.57503592561199 PubchemFP442 1.89068086730718
PubchemFP443 6.77712137438782 PubchemFP445 6.12819279620185 PubchemFP446 7.14796991508087
PubchemFP447 6.00680090594806 PubchemFP448 0.372792695608645 PubchemFP449 5.50516775015453
PubchemFP450 5.21918842891525 PubchemFP451 4.47471208103286 PubchemFP452 5.18273030039527
PubchemFP453 4.19749746532141 PubchemFP454 2.01692454752922 PubchemFP456 1.12735564479396
PubchemFP457 1.60718972812291 PubchemFP458 3.51984687277312 PubchemFP459 3.37130612341431
PubchemFP460 2.85266579809528 PubchemFP461 3.33177583990828 PubchemFP462 3.18599434048464
PubchemFP464 3.60750159194424 PubchemFP465 3.90677506855977 PubchemFP466 5.52012303862084
PubchemFP467 3.39460650696399 PubchemFP469 -5.26721868140873 PubchemFP470 1.6180970561359
PubchemFP471 5.42360691101173 PubchemFP472 4.67507549600245 PubchemFP473 -0.814209982952209
PubchemFP474 0.401329694172159 PubchemFP475 -1.56324253977545 PubchemFP476 4.55216732134435
PubchemFP477 5.14785502585983 PubchemFP480 3.24333623997205 PubchemFP481 1.30876010660605
PubchemFP482 3.07146429821919 PubchemFP483 1.96559736229943 PubchemFP484 2.99495862344323
PubchemFP485 5.93458072848073 PubchemFP486 1.47225521340665 PubchemFP487 6.03708878810751
PubchemFP489 3.92252978506795 PubchemFP490 -0.9280521714391 PubchemFP493 6.63140863030357
PubchemFP494 3.98229658846159 PubchemFP495 3.28696532373533 PubchemFP497 3.46772335273656
PubchemFP498 7.70609625000351 PubchemFP499 6.97276370633235 PubchemFP500 3.98479696672869
PubchemFP501 4.50592487403344 PubchemFP504 3.78859803000591 PubchemFP505 1.60981016306985
PubchemFP506 4.59716260151855 PubchemFP507 2.99515867852789 PubchemFP508 3.55808009853669
PubchemFP509 2.55208116094845 PubchemFP514 10.9918308545105 PubchemFP515 4.55128831261286
PubchemFP516 2.51288511619888 PubchemFP517 2.77771869519761 PubchemFP518 2.26737481746071
PubchemFP519 4.6138733903676 PubchemFP520 1.94116788257729 PubchemFP521 1.58288340364081
PubchemFP523 3.56768282254476 PubchemFP524 1.10694547700385 PubchemFP530 3.30851941482973
PubchemFP531 3.2378356836697 PubchemFP533 3.31314008662504 PubchemFP534 1.95351664451381
PubchemFP535 8.83534787145628 PubchemFP536 6.94372564053958 PubchemFP537 3.39601336048591
PubchemFP538 4.80298461999938 PubchemFP539 -1.31847614534175 PubchemFP540 6.93140954412761
PubchemFP541 4.47114643376621 PubchemFP543 5.82551019491804 PubchemFP544 4.72603200421132
PubchemFP545 2.99474793858952 PubchemFP547 6.16812717225098 PubchemFP548 11.3010203611482
PubchemFP549 2.7857825431307 PubchemFP550 4.87871044467945 PubchemFP551 3.30743855365824
PubchemFP552 0.976718408651143 PubchemFP553 6.4737505907108 PubchemFP554 2.55004179417825
PubchemFP555 2.68378730604056 PubchemFP556 -0.0686857737248161 PubchemFP558 3.08641772865379
PubchemFP560 6.28554178091023 PubchemFP563 10.6732220040996 PubchemFP564 -0.445371896518721
PubchemFP565 4.53087247311992 PubchemFP566 7.17554139962095 PubchemFP567 5.00127608787197
PubchemFP568 5.4455399003224 PubchemFP569 4.25020973642612 PubchemFP570 2.30777293202477
PubchemFP572 4.85725342307502 PubchemFP573 4.47504018434535 PubchemFP574 9.76625252156855
PubchemFP575 4.02880713759012 PubchemFP577 6.29298535672695 PubchemFP578 2.5749380551831
PubchemFP579 8.26442243570094 PubchemFP580 4.66391204871644 PubchemFP581 27.9696333388053
PubchemFP582 1.84037036112381 PubchemFP583 2.39764652202969 PubchemFP584 0.969477165992181
PubchemFP585 3.34929471103096 PubchemFP586 4.92269702497268 PubchemFP588 2.03007766930869
PubchemFP589 2.2732471889675 PubchemFP591 5.09692096324374 PubchemFP592 2.75131363655324
PubchemFP593 4.54350841374802 PubchemFP594 2.79685799288655 PubchemFP595 2.08518926057958
PubchemFP596 2.60368011892957 PubchemFP597 6.14590987361902 PubchemFP598 4.57932977987381
PubchemFP599 3.68396556548328 PubchemFP600 5.2884064814872 PubchemFP601 4.68228623986897
PubchemFP602 7.39870667345028 PubchemFP603 2.07463687344364 PubchemFP604 10.8641684868701
PubchemFP605 3.96634076715873 PubchemFP606 2.49122441987923 PubchemFP607 2.75960044424834
PubchemFP608 2.29283584713639 PubchemFP609 4.32009683062746 PubchemFP610 2.13691375432355
PubchemFP611 4.2716988873397 PubchemFP612 4.67553129458909 PubchemFP613 4.22698952030245
PubchemFP614 4.00395937732994 PubchemFP615 5.65792372189169 PubchemFP616 5.11604468772715
PubchemFP618 1.69037843891179 PubchemFP619 3.82511272781075 PubchemFP620 2.52987672527921
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PubchemFP621 3.17497870167321 PubchemFP622 -3.02296078745084 PubchemFP623 5.06394296582221
PubchemFP624 4.71623850307325 PubchemFP625 5.55451514734 PubchemFP626 4.39100495412665
PubchemFP628 2.29632140490542 PubchemFP629 4.4223016640676 PubchemFP630 2.40844067796125
PubchemFP632 4.08708178732379 PubchemFP633 4.29359596074767 PubchemFP634 1.42667250315176
PubchemFP636 3.43649989898118 PubchemFP637 5.52996968332022 PubchemFP638 5.09714454423596
PubchemFP639 2.69481924162362 PubchemFP640 1.88757879795377 PubchemFP641 4.53769958143171
PubchemFP642 27.0601167724226 PubchemFP644 2.84113840804731 PubchemFP645 9.86212787862481
PubchemFP646 2.6321840370175 PubchemFP647 2.07378140282095 PubchemFP648 1.75248364303548
PubchemFP650 4.42575979416326 PubchemFP651 4.20100687021814 PubchemFP652 4.47385012169164
PubchemFP653 2.82027885072289 PubchemFP654 4.37603537236683 PubchemFP655 6.44163779513853
PubchemFP656 4.03493612939661 PubchemFP657 2.92315819106799 PubchemFP658 7.22433660905773
PubchemFP659 7.17280895665109 PubchemFP660 0.958333421722222 PubchemFP661 11.458658877799
PubchemFP662 1.72082057348523 PubchemFP664 1.6945816021818 PubchemFP665 5.45115928656079
PubchemFP666 3.89269094875753 PubchemFP668 1.30863217728908 PubchemFP669 2.0895920122979
PubchemFP670 1.93228403229391 PubchemFP671 6.7302239130789 PubchemFP673 7.09929022582835
PubchemFP674 3.9119424096432 PubchemFP675 2.15500675496966 PubchemFP676 4.82736279895433
PubchemFP677 2.5293326431561 PubchemFP678 0.197702059495728 PubchemFP679 1.20592524141585
PubchemFP680 4.0622691426491 PubchemFP681 6.7419978822189 PubchemFP682 8.51689126994464
PubchemFP683 4.14336952712752 PubchemFP684 5.95082235402873 PubchemFP685 5.82310763557059
PubchemFP686 11.9195790396474 PubchemFP687 8.74591071291774 PubchemFP688 7.95761425981889
PubchemFP689 4.50133437206196 PubchemFP690 4.44327896832754 PubchemFP691 7.18718209149912
PubchemFP692 7.35866348098259 PubchemFP693 2.94815080252367 PubchemFP694 1.49549911204744
PubchemFP695 5.90317108706607 PubchemFP696 4.43363777984911 PubchemFP697 12.064287358764
PubchemFP698 7.75385074638105 PubchemFP699 4.84872784625022 PubchemFP700 3.83975380672992
PubchemFP701 4.84094504516875 PubchemFP702 6.4941292407227 PubchemFP703 5.52189139152706
PubchemFP704 6.25731917230476 PubchemFP705 5.20363699174505 PubchemFP706 -3.84713439720219
PubchemFP707 5.63051099370526 PubchemFP708 2.02458060596262 PubchemFP709 3.72399950866053
PubchemFP710 4.89398859268389 PubchemFP711 2.31212735130673 PubchemFP712 6.51287254474513
PubchemFP713 7.82788633718858 PubchemFP714 4.78624977887842 PubchemFP715 2.18320397418448
PubchemFP716 7.75276579735395 PubchemFP717 3.23486059966949 PubchemFP719 2.78037432362557
PubchemFP721 5.79794679493236 PubchemFP722 2.70014370866021 PubchemFP725 1.91898883345123
PubchemFP728 8.96020904281336 PubchemFP729 2.26247791222309 PubchemFP733 2.13005127847135
PubchemFP734 7.26393265336201 PubchemFP735 5.63684177371791 PubchemFP736 2.68622466683074
PubchemFP737 4.7042622371881 PubchemFP738 4.62159281242579 PubchemFP740 2.82308005477814
PubchemFP742 3.72697750998243 PubchemFP743 2.12953045525639 PubchemFP745 0.0965815318655915
PubchemFP746 4.47757572788864 PubchemFP747 3.10203560533094 PubchemFP749 5.79671436381013
PubchemFP750 7.36607070220743 PubchemFP751 2.52895272812964 PubchemFP752 2.88374365578634
PubchemFP755 7.61766951028283 PubchemFP756 3.18285065818063 PubchemFP757 3.97615585482496
PubchemFP758 5.83777271077832 PubchemFP759 5.03059456806628 PubchemFP761 3.44012266495051
PubchemFP762 -1.35063748856266 PubchemFP763 4.57950724350519 PubchemFP764 1.29667013673279
PubchemFP766 2.2768855199181 PubchemFP767 2.59930089137576 PubchemFP770 3.70987345977093
PubchemFP771 6.23106196522795 PubchemFP772 2.23263494755983 PubchemFP776 6.32974621974487
PubchemFP777 3.78456347039323 PubchemFP778 2.67462656524088 PubchemFP779 8.34264400242892
PubchemFP780 3.63263890476523 PubchemFP782 3.76116872125897 PubchemFP784 5.36957295907781
PubchemFP785 2.27504460619906 PubchemFP788 0.338941399589503 PubchemFP791 9.15982669586266
PubchemFP792 2.26495409767388 PubchemFP796 1.78447252756069 PubchemFP797 4.9497341184137
PubchemFP798 6.13544148535155 PubchemFP799 2.33774904519446 PubchemFP800 4.23295693769458
PubchemFP801 4.48256769611401 PubchemFP803 2.81362211500564 PubchemFP805 4.2996488393107
PubchemFP806 1.51978947975468 PubchemFP808 1.50328685991531 PubchemFP809 3.02882666337605
PubchemFP810 1.7826981139546 PubchemFP812 7.1862488055385 PubchemFP813 7.68098343301358
PubchemFP814 2.90107068454887 PubchemFP815 2.01944324185055 PubchemFP818 6.41825368458259
PubchemFP819 5.99202556570906 PubchemFP820 4.04767113162199 PubchemFP821 5.89612814381938
PubchemFP822 4.31272861342466 PubchemFP824 3.68546224899147 PubchemFP825 -4.30129695367445
PubchemFP826 5.32174039421538 PubchemFP827 2.207521843622 PubchemFP829 1.62528831490701
PubchemFP830 2.91065006406725 PubchemFP833 3.62178044505095 PubchemFP834 4.17354658912499
PubchemFP835 2.15049083106929 PubchemFP839 1.33275964914727 PubchemFP840 -4.32941994444933
PubchemFP860 -3.84860754898041 PubchemFP861 -4.87338272744492 nAcid 3.49490130539136
apol 8.48102679142272 naAromAtom 13.8925495441836 nAromBond 12.6210249219444
nAtom 7.12939176939597 nHeavyAtom 4.99173586322448 nH 15.9418528358722
nB 9.27965047936655 nC 12.5529729732747 nN 7.05734607567905
nO 9.95508199545984 nS 6.6745996736291 nP 1.0898215540106
nF 10.730670521147 nCl 8.88726961794345 nBr 1.63459614396592
nI 4.51569500115588 ATSc1 13.4689406262689 ATSc2 18.2322812492603
ATSc3 30.4195755388618 ATSc4 22.8056178174134 ATSc5 23.5315343023311
ATSm1 12.8377251815208 ATSm2 8.06156518811558 ATSm3 6.0189999387248
ATSm4 10.4470480358729 ATSm5 10.566960878491 ATSp1 9.04873423973322
ATSp2 7.8206102007326 ATSp3 10.2001215560857 ATSp4 10.3443349627243
ATSp5 9.87404272910894 nBase 11.5100191470814 nBonds 6.29532067260421
nBonds2 10.769935480839 nBondsS 11.6043143609767 nBondsS2 10.1707400194455
nBondsS3 11.9643891195926 nBondsD 13.0307317692353 nBondsD2 15.0423083722397
nBondsT 3.0191766944979 bpol 7.25398232221872 C1SP1 3.84094222664992
C2SP1 2.95845540924336 C1SP2 10.7701568308379 C2SP2 19.0279216432238
C3SP2 21.3609908441646 C1SP3 13.9613625059444 C2SP3 10.8476864277824
C3SP3 9.03812138075901 C4SP3 4.78372134664915 SCH.3 2.91348509221845
SCH.4 7.73312698567442 SCH.5 13.0543283620492 SCH.6 19.4752096154005
SCH.7 18.0860996023325 VCH.3 3.68491877170265 VCH.4 8.20131055348199
VCH.5 15.4296040148552 VCH.6 15.4113735217743 VCH.7 24.6603290395259
SC.3 13.1940917578723 SC.4 14.9027251767708 SC.5 7.7793387086907
SC.6 12.5212770903705 VC.3 13.1084296457726 VC.4 24.4059536856909
VC.5 15.3416157389446 VC.6 12.0148644181644 SPC.4 9.61194894724826
SPC.5 12.4794186073521 SPC.6 10.1055271683703 VPC.4 12.7752221309617
VPC.5 11.8880440746878 VPC.6 12.3746726427276 ECCEN 12.8950563960889
fragC 15.8362958824824 nHBAcc 7.87080518864251 nHBAcc2 9.55755183446104
nHBAcc3 18.2863585121702 nHBAcc_Lipinski 6.43537887525071 nHBDon 30.5883830110861
nHBDon_Lipinski 11.4079213169022 nAtomLC 12.9082762665911 nAtomP 14.9174093692689
nAtomLAC 11.7173162580729 MLogP 24.3053918966804 McGowan_Volume 10.6627209176955
MDEC.11 9.48250616647548 MDEC.12 11.9277826502012 MDEC.13 14.660641146342
MDEC.14 11.0529690892909 MDEC.22 23.5675769414648 MDEC.23 13.2928795754932
MDEC.24 16.964993807552 MDEC.33 14.1633464639132 MDEC.34 17.6183940316126
MDEC.44 3.93356944754529 MDEO.11 19.7373362333804 MDEO.12 40.801185683445
MDEO.22 4.34403408294465 MDEN.11 9.0106577902956 MDEN.12 10.2103834721596
MDEN.13 28.5854186527228 MDEN.22 14.9454125602534 MDEN.23 12.2460571986371
MDEN.33 10.184012824124 MLFER_A 14.1597054638882 MLFER_BH 13.8323440432494
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MLFER_BO 19.7038587126037 MLFER_S 11.7461094465931 MLFER_E 17.3803523769754
MLFER_L 25.4229283688413 PetitjeanNumber 15.9210997747369 nRing 6.01002682580881
n3Ring 1.54277734155562 n4Ring 1.2968866445264 n5Ring 9.72420155380451
n6Ring 13.3742282437302 n7Ring 0.926358329656961 n8Ring -4.91969951265647
n9Ring 0.977539993342432 n10Ring 0.766230159511356 nG12Ring 2.58521494459324
nFRing 8.51980532310474 nF6Ring -0.138635046570875 nF8Ring 2.19925034660949
nF9Ring 7.41628130436968 nF10Ring 11.003879064936 nF11Ring 2.26180826388436
nF12Ring 5.42505362847208 nFG12Ring 8.71912337688775 nTRing 10.1611165773085
nT4Ring 0.941460825224625 nT5Ring 9.78110980250178 nT6Ring 13.9143029733709
nT7Ring 1.01217580346026 nT8Ring 1.31055762509429 nT9Ring 8.46370117148573
nT10Ring 9.88445788351116 nT11Ring 3.12038276872752 nT12Ring 4.60550749534969
nTG12Ring 7.94720887311358 nRotB 14.3531351555421 TopoPSA 18.7343576012179
VAdjMat 5.18745526813097 MW 11.6759680577346 WTPT.1 6.94995896695379
WTPT.2 15.0451696161186 WTPT.3 12.5384014051668 WTPT.4 17.9765807321768
WTPT.5 15.2343458543523 WPATH 18.493999907808 WPOL 9.27140414065025
Zagreb 7.66041017301296
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